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Our little systems have their day
They have their day and cease to be
They are but broken lights of Thee
And Thou o Lord art more than they
   Alfred Tennyson (1809-1883)
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Chapter 1
 Introduction  1.1  the storage of nutrients
    1.2  impaired liver glycogen storage in cirrhosis?
    1.3  the aim of the study
1.1  The storage of nutrients 
Eating is an episodic phenomenon in man. The majority of the human beings consumes two or three 
meals during the day and goes without food for a period of eight to twelve hours during the night. 
In contrast to the intermittent intake, the utilisation of food by the body is relatively constant for most 
of the body organs. In some organs, like skeletal and cardiac muscle, the energy expenditure can 
fluctuate substantially, but such fluctuations are usually independent of the time of eating. This entails 
the need to store energy and nutrients to be utilised during the fasting periods.
 
In other words the capacity of the human body to store energy and nutrients makes it possible to eat 
periodically.
Of the three major foodstuffs – fat, carbohydrate and protein – only the first two have an identified 
storage place. Fat is stored in adipose tissue and carbohydrates are stored as glycogen in liver and 
skeletal muscle. The amino acids derived from protein intake are “stored” as proteins in the body 
cells. 
An excess of carbohydrate or protein will be converted to triglyceride and stored as such. 
Under normal circumstances the healthy human body is able to handle a wide variety of foodstuffs in 
which the proportion of fat, protein and carbohydrate may vary substantially.
For instance a diet based almost entirely on unpolished rice contains about 85% of the total energy 
intake as carbohydrate, 10% as protein, and 5% as fat; while a meat diet contains less than 5% as 
carbohydrate, about 40 % as protein and 55% as fat. Both these diets are eaten habitually in some 
parts of the globe and both can be adequate. [1] 
However the ability of man to thrive under different dietary circumstances does not mean that the use 
of the different nutrients is equally efficient.
If there is a imbalance between the intake and the consumption of protein, fat and carbohydrate, the 
body is often able to compensate by converting for instance protein and glycerol into carbohydrate, 
(gluconeogenesis). However these converting processes are inefficient and limited. [1,2]
1.2  Impaired liver glycogen storage in cirrhosis?
In 1984 and 1989 Swart et al. postulated that an impaired glycogen storage capacity in the liver could 
cause an early shortage of liver glycogen and as a result an enhanced gluconeogenesis in patients 
with cirrhosis. This concept was based on the observation that the nitrogen balance in patients 
with cirrhosis of the liver improved when meal frequency increased. In these experiments the total 
amount of dietary input and the composition of the diet did not change. They postulated that when 
there is a long period between two meals, the body usually draws on the glycogen stored in the liver 
for its carbohydrate supply. If there is a shortage of liver glycogen, glucose will be formed through 
gluconeogenesis. The main substrate of gluconeogenesis is protein. An increased gluconeogenesis 
entails increased proteolysis and thus a more negative nitrogen balance during fasting. Frequent 
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periods of proteolysis could result in muscle wasting. Muscle wasting is often observed in patients 
with cirrhosis. An increased meal frequency provides a more even dietary carbohydrate supply from 
the gut. This reduces the need for glycogenolysis from liver glycogen and if there is a shortage of 
liver glycogen, less demand for gluconeogenesis. A reduced gluconeogenesis will in turn results in 
less protein utilisation. Indeed the nitrogen balance was found to be less negative in cirrhotics while 
on an increased meal frequency. [3-5] 
These findings were confirmed by an experiment that showed that nocturnal oral glucose sup-
plementation improved nitrogen balance in patients with cirrhosis, while it had no effect in healthy 
volunteers. [6] 
 
Following this concept, guidelines were proposed to prevent muscle wasting in patients with cirrho-
sis. Food intake should be spread over the day and a late evening meal is advised. The protein intake 
of patients with cirrhosis should be about 1 gram per kilogram bodyweight per day. [4,5,7,8]
In a recent study Peterson et al provided confirmatory evidence for the above hypothesis. They com-
bined 13C nuclear magnetic resonance spectroscopy (NMR) and stable isotope [6,6-2H2]glucose infu-
sion techniques to determine liver glycogen content, liver glycogen depletion and glucose production 
over a period of five to thirteen hours postprandially. In cirrhosis the postprandial hepatic glycogen 
concentrations were 34% lower than those in healthy controls. Gluconeogenesis as percentage of 
glucose production was markedly increased in cirrhosis, 87% vs 60% in controls. [9] 
1.3  The aim of the study
In order to obtain a better insight into the postulated early glycogen depletion and increased glu-
coneogenesis, we wanted to study glycogen depletion of the liver in more detail during the early 
postprandial phase. A better understanding of the pathophysiology should provide a basis for a more 
individual advice regarding diet and nutritional intervention. Development of an easily applicable 
bedside test could help to select patients who would benefit from dietary treatment.  This in turn 
could reduce morbidity by preventing muscle wasting and possibly by improving the immune status 
of patients with cirrhosis of the liver. 
However, no easily accessible method to study liver glycogen depletion was available. In the past, 
glycogen concentrations have been measured in serial liver biopsies. [10-12] More recently, various 
catheterisation techniques, indirect calorimetry and nuclear magnetic resonance (NMR) techniques, 
sometimes combined with isotopic tracers, have been used to study liver glycogen, hepatic glucose 
output and substrate oxidation. [13-24] 
The research described in this thesis was aimed at exploring the liver glycogen depletion by a new 
method based on a selective labelling of the liver glycogen pool by a natural label, the 13C-isotope. 
[25,26]  The intention was to develop a reliable, reproducible and relatively, easily applicable non-
invasive test.
The theoretical background and the design of the method are presented in chapter 2. 
Various aspects of the concept on which the model is based were tested and are described in chapter 
3. They include studies on the distribution of the 13C isotope in exhales CO2 of a control population 
and the short and long term reproducibility.
Chapter 4 deals with different aspects of the model. The course of 13C enrichment in breath CO2 after 
a 13C-enriched diet was studied. The influence of a higher 13C-enrichment of the muscle glycogen 
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was measured and analysed. The test was carried out inversely in a population used to a 13C-en-
riched diet. The model was tested on its reproducibility and a 1-day labelling period was compared 
with a 3-day period of labelling with a naturally 13C-enriched diet. Results of initial tests of the model 
used in patients with cirrhosis are presented in chapter 5. Chapter 6 ends this thesis with a general 
discussion and conclusions.
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Chapter 2
 The model  2.1  glycogen metabolism
    2.2  the use of 13C in metabolic studies
    2.3   the design of the experimental model 
2.1  Glycogen metabolism
As more than 99 % of carbohydrate absorbed by the human body is used for energy production, a 
considerable part of the absorbed carbohydrate needs to be stored in the form of glycogen for later 
use. The formation of the polysaccharide glycogen occurs in small amounts in practically all body 
tissues. However substantial glycogen stores are only found in liver and muscle tissue.
A normal human adult with a body weight of 70 kg will have about 72 gr. of glucose stored as gly-
cogen in the liver (4% of a liver of 1800 gram), 245 gr. of glucose  in skeletal muscle (0.7% of 35 kg 
muscle mass) and 10 gr. of extracellular glucose (0.1% of 10 litre). The human liver may contain up to 
6% of its wet weight as glycogen when analysed shortly after a carbohydrate rich meal. Muscle tissue 
contains rarely more than 1% of its wet weight as glycogen. The function of the muscle glycogen is 
to be an energy source for the muscle itself. In contrast, the liver glycogen pool is used to maintain 
an adequate supply of glucose to different organs during the postabsorptive period, mainly during 
the night. [1-3] 
Figure. 2.1 the interconcersion of the three major monosaccharides, the glycogenesis and glyco-
genolysis in the liver cell
fructose galactose
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fructose-6-phosphate glucose-6-phosphate galactose-6-phosphate
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uridinediphosphategalactose
glucose
BLOOD
CELL
Cell membrane
The model
boek_19-03-'03 19-03-2003, 15:5013
14 15
Transcellular membrane monosaccharide transport
The final products of carbohydrate digestion within the alimentary tract are almost entirely the three 
monosaccharides glucose, fructose and galactose. Of these three, glucose represents about 80 
percent under most conditions.
During the process of absorption and transport through the epithelial cells into the portal blood most 
of the fructose is also converted to glucose. The remaining fructose is then, along with galactose, 
converted into glucose by the liver. And so the final destination of almost all digested carbohydrate is 
glucose, as shown in figure 2:1.
In the epithelial cells of the alimentary tract the monosaccharides are taken up by active sodium co-
transport.
The same process occurs in glucose transport through renal tubular cells. 
For all other cell membranes the monosaccharide trans-membrane transport is by a process of a 
facilitated diffusion. Monosaccharides are only transported from higher concentration toward lower 
concentration by the special binding properties of the glucose carrier.
The rate of the trans-membrane transport of monosaccharides is greatly increased by the presence 
of insulin. The only exception to this is the liver, which is able to take up glucose more easily than 
other tissues. [4,5]
 
Upon entering the cell glucose is transformed to glucose-6-phosphate. This reaction is facilitated by 
the enzyme glucokinase. 
In the liver cell galactose and fructose are transformed to galactose-6-phosphate and fructose-6-
phosphate. See fig 2:1.
This phosphorylation of monosaccharides is almost completely irreversible. This means that once a 
monosaccharide-6-phosphate molecule is formed the monosaccharide molecule is “trapped” in the 
cell to be used as fuel within that cell.
Three exceptions to this rule are the liver cells, the epithelial cells of the renal tubules and the intes-
tinal cells. These cells contain the enzyme glucose phosphatase, which makes it possible to reverse 
the process and to make glucose available to recross the cell membrane. [1,2]
 
Glycogenesis
The formation of a glycogen molecule begins with the formation of a primer molecule, glycogenin. 
Glycogenin undergoes a self-glycosylation to generate an oligosaccharide primer. The enzyme gly-
cogen synthetase then enables the reaction to elongate the polysaccharide chain, leading ultimately 
to the formation of glycogen. [6,7] The glycosylation of glycogenin is probably determined by the bal-
ance between the self-glycosylation of glycogenin and the opposing action of the enzyme glycogen 
phosphorylase. [8]
An intermediate in the glycogen pathway is proglycogen. Proglycogen is the low molecular mass 
form of glycogen that serves as a stable intermediate in the pathways to and from depot glycogen. 
It has been suggested that glycogen oscillates, according to glucose supply and demand, between 
the macroglycogen and the proglycogen, but usually not the glycogenin, forms. The glycogenin mass 
is 37kDa, the proglycogen mass is approximately 400 kDa and the (macro)glycogen has a mass of 
about 107 kDa  The proportion of proglycogen to total glycogen varies in different organs from 3% in 
liver, 15% in skeletal muscle to 50% in heart tissue. [9]
The actual amount of glycogen stored in the liver and muscle cells depends on the amount of glyco-
genin, the type of cell and the previous demand. Less glycogenin means less glycogen formation, at 
least in skeletal muscle. [10] 
Chapter 2
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Figure 2.2  Pathway of glycogenesis and glycogenolysis in the liver.
The liver cell needs less glycogenin to form the same amount of glycogen compared with muscle 
glycogen. This can be explained by the formation of larger glycogen molecules or by the presence of 
still unknown glycogenin-like proteins. The latter could be the case since recently a second human 
gene, CYG2, encoding a liver specific isoform of glycogenin, glycogenin-2 was reported. [11,12] 
It has been reported that after rigorous exercise more glycogen is formed in skeletal muscle than 
without such an exercise. This process is dependent on the production of primer proteins. [10]
In spite of extensive research the exact mechanisms controlling glycogen biogenesis are still poorly 
understood. [10] There is evidence that glycogenin plays a role as regulator and initiator. Other fac-
tors influencing the glycogenesis are insulin, glucagon, glucose, lactate, adrenaline [13], islet amy-
loid polypeptide (or amylin) [14], lipids [15,16], cortisol [17] and glutamine. [18]
The glycogenesis pathway is illustrated in figure 2:2. 
It is obvious that any compound that can be converted into glucose or glucose-6-phosphate can en-
ter into these reactions. Examples are the monosaccharides galactose and fructose, but also lactic 
acid, glycerol, pyruvate and some de-aminated amino acids.
The enzyme glycogen synthetase exists in an inactive form (b form) and an active form (a form). 
Cyclic AMP and compounds stimulating the formation of cyclic AMP, like adrenaline, insulin and 
thyroid hormone initiate the transformation of the enzyme from its inactive to its active form. Through 
this pathway glycogen formation is stimulated.
Glycogen formation takes place by the process of linking the C1 of the glucose moiety of the uridine 
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diphosphate glucose (UDPG) to the C4 of a terminal glucose of the glycogen molecule, through the 
action of glycogen synthetase (or glycosyltransferase).
After the addition of between 6 and 11 glucose residues, the branching enzyme amylo-1,4à 1,6-
transglucosidase acts on the molecule. Through this process a large branched glycogen molecule 
can be created which is, due to its open structure, very accessible for quick and efficient mobilisa-
tion of glucose when required. “Mobilising” enzymes have a good access even within the molecule. 
Figure 2:4. 
During glycogen synthesis large granules are formed in the cytoplasm. Such granules have a diame-
ter of 100-400 Å and consist of a number of polysaccharide molecules, B-particles that are covalently 
linked to form larger A-particles. 
Figure 2.3  The debranching of the glycogen molecule. Through the glycogen phosphorylase 
glucose-1-phosphate is formed. However glycogen phosphorylase is unable to remove the re-
maining 4 glucose residues. Debranching enzyme glucotransferase moves three of those resi-
dues to a free C-4 end of a second branch. The last residue is than removed by the debranching 
enzyme glucosidase. 
P
p
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Proteins are also present in the granules, as well as enzymes participating in the synthesis and 
breakdown of polysaccharides. 
The branched structure of the glycogen molecule is very well suited for its metabolic function. This 
structure makes it possible to store a large amount of glucose in a small volume [hardly affecting the 
osmotic pressure in the cell] and at the same time allows a very rapid release of substantial amounts 
of glucose when needed. 
Glycogenolysis
The process of mobilising the glucose molecule from glycogen, glycogenolysis, is not simply the 
reversal of the glycogenesis pathway. Glycogenesis and glycogenolysis are catalysed by a different 
set of enzymes.[19-21] This makes it possible to facilitate both glycogenesis and glycogenolysis at 
the same time. Such a construction enables a quick response of both formation and utilisation of 
glycogen to a changing demand. 
The glycogenolysis pathway is illustrated in figure 2:2, with the debranching process shown in figure 
2:3. 
Figure 2.4 A cartoon of the branched structure of the glycogen molecule.
����
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 Gluconeogenesis
Gluconeogenesis is the process through which the body is able to convert noncarbohydrate pre-
cursors into glucose. The glucose generated through this pathway can be used for oxidation or to 
restore the depleted glycogen stores. The principle organs in the human body responsible for glu-
coneogenesis are the liver and the kidney. These two organs are equipped with a set of enzymes to 
facilitate the process of gluconeogenesis. 
The compounds used for this process fall into two categories.
In the first category there is a conversion of compounds to glucose without significant recycling. 
Examples of these compounds are some amino acids and propionate.
In the second category there are the products of the partial metabolism of glucose in certain tissues 
that are resynthesized to glucose after they have been conveyed to the liver and kidney. Examples 
of these compounds are the lactic acid cycle (Cori cycle), the glucose – alanine cycle (the required 
energy is derived from fatty acid oxidation) and the cycle in which glucose is transported from the 
liver and kidney to adipose tissue and glycerol is returned to be synthesized  into glucose by the liver 
and kidney.
In healthy subjects gluconeogenesis accounts for 50% to 60% of the glucose production after an 
overnight fast. [22-24]
Cycling of glucose carbon atoms
Simultaneous synthesis and breakdown of a substance is called cycling. Such cycling is possible 
when there are 2 separate metabolic pathways for synthesis and breakdown or when the same path-
way is used in the opposite direction at a different location.
The central molecule in the cycling of glucose and glycogen is glucose-6-phosphate. Re-cycling in 
the context of glycogen-metabolism means the recycling of carbon atoms from glycogen or glucose 
via other molecules back to glucose and glycogen. Because of the uncertainty about the extent of 
(re)cycling and the complexity of the processes involved, cycling has been a matter of concern and of 
debate over the past years. Landau discussed this in a recent paper. He mentioned that even on the 
point of the definition of cycling there is no unity. The different methods used to study the glycogen 
metabolism are based on different assumptions. This does not make it easy to compare the results 
from different studies. [25]
Lactate and alanine are the predominant substrates by which glucose carbons can recycle back to 
the liver for production of new glucose. [26]
Combining the results of recent studies it can be concluded that cycling is undetectable in healthy 
humans after an overnight fast. However such cycling may be of importance in diabetes and the 
response to severe stress. Certain hyperinsulinemic and hyperglucagonemic conditions could play 
a role. It is therefore possible that the hyperglucagonemic conditions in cirrhotic subjects promote 
cycling. [23,25-27] 
Last in – first out?
When (liver) glycogen metabolism is studied with the aid of tracers or labelled substrate, the question 
arises if the glycosyl units of the glycogen molecule that have been most recently synthesized are 
the first to be removed. There is some experimental evidence supporting the hypothesis that the last 
incorporated glycosyl units are the first to be removed. When radioactive galactose was infused in 
rats and glycogen was isolated from the rat liver and degraded, the radioactive units were liberated 
first. [28]
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In another experiment radioactive galactose was infused into dogs. Following administration of glu-
cagon, the labelled glucose appeared first in the circulation. [29]
On the other hand, there is evidence that the last-deposited-first-removed hypothesis is at least far 
from absolute. Magnusson labelled liver glycogen with [1-13C]glycosyl units. After the labelling he 
infused a substantial amount of unlabelled glucose. Despite the administration of large amounts of 
unlabelled glucose after the 13C-glucose, the 13C-label disappeared from the liver at an early stage. 
[30]
Incorporation of label at different sites of the glycogen granules could be an explanation for the phe-
nomenon of the last-deposited not being first removed. Synthesis and breakdown in different areas of 
the liver lobules could also be an explanation. Thus, the order of release of glycosyl units of glycogen 
in relationship to the time of their deposition remains uncertain. In most studies, using isotopes, NMR 
or both, it is assumed that the last-in-first-out hypothesis does not hold. [25]
2.2  The use of the 13C isotope in metabolic studies
13C is one of the eight known carbon isotopes. 12C and 13C are stable isotopes, while the other six 
are radioactive. The half-life time of the radio-active isotopes is short with the exception of the 14C-
isotope, which has a half-life decay of over 5700 years. (See Table 2:1)
Table 2:1 – Carbon isotopes
 Type  9C 10C 11C 12C 13C 14C 15C 16C
 Half-life  127 19.5 20.3 stable stable 5730 2.45 0.2
   (ms)   (s) (min)   (years)   (s)  (s)
 Natural abundance (%)   ±98.9 ±1.1 10-10
ms = milliseconds;  s = seconds;  min = minutes
Rudolf Schönheimer (1898-1941) introduced the concept of using stable isotopes for labelling or-
ganic compounds in order to assess their metabolic fate. [31]
Only fairly recently, when the potential biological hazards and the special problems of the long half-
life time of the 14C isotope came into general perception, did the use of the stable 13C isotope become 
more popular for metabolic studies. The main reason for this delay was the technical difficulty and 
complex methodology for measuring the stable isotopes as compared with the 14C technology. [31-
33]
After oxidation carbon atoms end up in the breath as CO2. Therefore *C-enrichment of breath CO2 
can be used in metabolic studies. [32-38]
In addition to the 14C-isotope being radioactive and the 13C-isotope being stable, there is another 
major difference between the two. 13C is present in relatively high concentrations the human body 
(approximately 1,08%) while 14C forms less than 0.0001% of the total body carbon.
This, for instance, makes the use of the 13C-glycocholic not applicable as a diagnostic breath test. 
The model
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The amount of labelled substrate required to induce a measurable increase of the 13CO2/
12CO2 ratio 
in breath is in the range of 800 mg. This amount is no longer a tracer dose (as with the 14C-labelled 
substrate) but a pharmacological dose causing diarrhoea.[31] Because of this difference in isotopic 
concentration not all the results produced by 14C-studies can automatically be transposed to 13C-
studies.
13CO2 tests are based on the fact that the oxidation of the administered labelled substrate can be 
measured by an increase in 13CO2/
12CO2 ratio in breath. A fundamental prerequisite for this is that the 
excretion of the labelled substrate, which is reflected by the ratio of breath 13CO2/
12CO2 over time, can 
be used to assess a defined rate-limiting step in the overall metabolic process. 
The specificity of the 13CO2 test is thus defined by the respective substrates and by the test condi-
tions. [31,32] 
 
A third difference between the 14C and 13C isotopes is that the 13C abundance is not completely 
steady in biologic materials. This variation is caused by so-called isotope fractionation as described 
by Hatch and Slack. There are two pathways in which carbohydrates are synthesised through pho-
tosynthesis, the C3 and the C4 pathway. Both pathways lead to the production of carbohydrates, but 
the carbohydrate produced has a slight difference in 13C abundance. Plants, that use the C3 pathway 
(Calvin-Benson cycle), produce carbohydrate with a relative low 13C-abundance of 1.082%. Plants, 
using the C4 pathway (Hatch-Slack pathway), are relatively 13C enriched, 1.096%. [39] 
This small but consistent difference can be exploited in breath tests using naturally 13C-enriched 
carbohydrate derived from C4 plants. 
Most plants used for human consumption use the C3 photosynthesis pathway. Examples of C4 
plants are corn, sugar cane, millet and pine-apple. [33]
Table 2:2 - Conditions for a simple breath test
 1. There should be a steady baseline label production
 2. Of the pathway that is studied one process is the rate limiting step
 3. The amount of label should be large enough to produce a significant signal but       
     should be small enough not to interfere with the studied (patho)-physiological process.
 4. The CO2 production should be steady or should be measured.
 5. There should be no cycling of the label or loss of label by other pathways
2.3  The design of the experimental model
We came to the following model:
 1. A person used to a C3-plant diet has a low 13C-abundance of all tissues.
 2. If such a person consumes (naturally) 13C-enriched carbohydrate, the glycogen pools  
     will become 13C-enriched. The fat and protein pool will stay at basal 13C-abundance, un 
     less the label is consumed for a long period. Since during a sedentary fasting period the  
     muscle glycogen is hardly used, the 13C-enriched liver glycogen pool is the sole source  
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     of 13C-enriched glucose during those conditions. The oxidation of such glycogen would  
     increase the 13C/12C ratio in breath CO2. 
 3. If the CO2 production is known it will be possible to calculate the amount of liver glyco 
     gen that is oxidized.
The model is not a classic tracer study as such. Liver glycogen is both label and substrate. This has 
an advantage of no interference due to administration of a large amount of labelled tracer during the 
test. [26] 
The following assumptions were made in developing the model:
 1. The CO2 production would be constant during the observation period. This assumption  
     was also tested.
 2. A one-compartment model for the CO2 pool, which is usually assumed in metabolic  
     studies using breath CO2 enrichment, would be applicable in this investigation.
 3. Cycling of labelled carbohydrate plays a negligible role during the observation  
     period. 
 4. Part of the C-atoms can be “lost” to other pathways. The model provides no tools to  
     indicate the proportion of such a loss. Since the label is measured at the end of the  
     oxidation pathway, only the C-atoms that reached this endpoint are accounted for. This  
     limits the results to that part of the liver glycogen, which is fully oxidized. Following Gay  
     we applied a correction factor of 0.8 [40] Re-cycling of enriched C-atoms will not be  
     meas ured by this method, since such atoms do not reach the breath as CO2. 
 5.The substrates for gluconeogenesis can be very diverse, but all those substrates will be  
    enriched with 13C at the basal level. Oxidation of such newly formed glucose and glyco 
    gen will not be detected by our model. The only exception will be lactate derived from  
    muscle glycogen, which could have a higher 13C-enrichment. Since the study is carried  
    out under sedentary conditions the lactate production will be very low. Zillekens found  
    lactate levels of 1.0 mmol/l after an overnight fast in both healthy subjects and patients  
    with cirrhosis of the liver. [41]
 6. The 13C-enriched carbohydrate is evenly distributed throughout the liver glycogen  
     granules.
 7. Muscle glycogen is hardly utilised during a sedentary fast. In combination with the fact
     that the non-enriched muscle glycogen pool is large the contribution of oxidised 13C-en 
     riched muscle glycogen is likely to be negligible. This assumption was tested.
 8. The intestinal absorption of carbohydrate is complete at four to six hours after the meal. 
 9. In the general population the 13C/12C ratio in exhaled CO2 is relatively constant and  
     within anarrow range. This assumption was tested.
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 Orientation studies 3.1 The distribution of the basal 13C-enrichment in breath 
                        3.2  The variation of the basal 13C-abundance in time
    3.3  The day to day variation of the basal 13C-abundance
    3.4  Conclusions
3.1 The distribution of basel ¹³C-enrichment in breath CO2
In order to use the 13C-enrichment in breath CO2 for comparative studies the basal 
13C-enrichment of 
the studied population should preferably follow a Normal distribution. [1]
We studied the basal 13C-abundance in breath CO2 of 244 persons attending our laboratory to un-
dergo a Helicobacter pylori breath test. We considered this group to represent the healthy Dutch 
population, like also our study population. Their particulars are presented in Table 3.1
TABLE 3.1 - Particulars of 244 consecutive persons attending the laboratory for a 13C Helicobac-
ter pylori breath test.
Age in yr. Number Male Female
00-09 2 1 1
10-19 5 4 1
20-29 23 10 13
30-39 29 17 12
40-49 59 29 30
50-59 58 24 34
60-69 37 16 21
70-79 26 13 13
80-89 4 1 3
90-99 1 1 0
Total 244 115 129
Breath samples were collected at the start of the breath test, after an overnight fast. 
The mean value of the 13C-abundance in breath CO2 was 1.0828 At% and the standard deviation 
0.00082.
The data follow a normal distribution as is shown in figure 3.1.
There were only 6 (2.4%) outlying data. The ethnic origin of the attendants could not be traced. 
Taking into account the multi-racial population of Rotterdam, which might mean different life-styles 
and different eating habits, there is a surprisingly small standard deviation. Others reported a 13C 
abundance of 1.0827 on the European continent. This in contrast to corn (13C-enriched) eating 
Americans, whom had a basal 13C abundance of 1.0882 At%. [2] 
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Figure 3.1  The distribution of the 13CO2 abundance in 244 persons attending the laboratory for a 
helicobacter breath test together with the calculated normal distribution.
3.2 Intra individual variation in basal 13C-abundance
Of the 244 persons attending for the 13C-urea breath test, 20 repeated the test after some time. The 
mean interval between the two measurements was 102 days, SD 34.
No significant difference was observed between the two basal values, as shown in figure 3.2.1 and 
3.2.2. The mean difference in 13C-abundance was –0.00026 At% with a standard deviation of the 
differences of 0.00089. This gives a 95% limits of agreement of 0.00152 and – 0.00204. As shown 
in figure 3.2.2 there was no trend in deviation over time. Very often Helicobacter pylori infection is 
initially diagnosed by means of an endoscopic procedure.  The 13C-urease breath test is mainly used 
to check the effect of Helicobacter eradication therapy. This explains the large proportion of single 
measurements in the study group. 
3.3 Day to day variation of basel 13C-abundance
The day to day variation of 13C abundance in breath CO2 was studied in ten healthy volunteers, 6 fe-
male and 4 male. All participants collected two breath samples before breakfast during five consecu-
tive days. There were no dietary restrictions during those days. The averages of the 2 daily measure-
ments were calculated and the difference between the two measurements was plotted against 
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Figure 3.2.1  The basal 13CO2 enrichment in two breath samples taken at two different days. The 
interval between the two samples varied between 50 to 180 days.
Figure 3.2.2  The difference in 13CO2 abundance between the first and the second sample in 
relation with the time between the two measurements. 
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Fig. 3.3.1 The daily variation in 13C abundance of exhaled CO2.
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the average. The standard deviation of the differences was 0.00035. Since the standard deviation 
of duplicate analyses of one breath sample is 0.0004 [personal communication JLD Wattimena] a 
standard deviation of the differences of 0.00035 of 2 samples taken the same morning before break-
fast is acceptable. 
The daily variation of the 13C abundance was also analysed (Fig. 3.3.1). The mean of the five days 
was calculated for each individual.
The difference from the mean was plotted against the mean. The standard deviation of the differ-
ences from the mean was 0.00037. This shows that the daily variation of the 13C abundance of breath 
CO2 is small and acceptable since the variation falls within 1.96 times the standard deviation for a 
duplicate analysis of one breath sample.
3.4  Conclusions
The observations described above show that the basal 13C-abundance in breath CO2 is distributed 
according to a Normal distribution. The study group had a reasonable size (n=244) and consisted 
of patients recruited from Rotterdam. No selection was made on ethnicity or habitual diet. Since the 
population of the city of Rotterdam is multi-cultural, different diets might be consumed in this group. 
In spite of this the distribution follows the normal distribution pattern with a mean in the expected 
range. 
This led us to conclude that the diet as used in the Rotterdam region does not cause too wide fluctua-
tions in the basal 13C-abundance.
The observations also show that there is hardly any variation in the individual basal 13C-abundance in 
breath CO2. This is true both for the day to day variation and for the long term variation, although the 
long-term observations showed a greater variance as compared with the variation within a week.
From this information we concluded that the basal 13C abundance could be used in the calculation of 
the planned studies and that the variation is within an acceptable range. 
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4.1
Human liver glycogen metabolism assessed with a 
13C-enriched diet and a 13CO2 breath test
A. A. Tanis, J. W. O. van den Berg, R. Kroneman, J. L. D. Wattimena,
T. Rietveld, B. H. B. Nieland and G. R. Swart.
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Abstract
Background  Adequate liver glycogen stores to maintain hepatic glucose output by glycogenolysis 
in the post-absorptive state are essential to prevent protein loss through gluconeogenesis. There are 
no simple techniques to monitor liver glycogen use.
Methods  In this study, we labelled liver glycogen with naturally 13C-enriched carbo hydrate and 
measured the pattern of 13CO2 excretion and the postprandial time during which oxidation of 
13C-
labelled liver glycogen was demonstrable by 13CO2 enrichment in breath. Two experiments were 
performed in 24 healthy volunteers.
Results  In the first experiment we observed that breath 13CO2 enrichment returned to baseline 
values at 20.3 (SD 2.3, n=12) hours postprandially, indicating exhaustion of the 13C-labelled liver 
glycogen at that time. In a second experiment, breath 13CO2 enrichment in the early hours of the post-
prandial phase was studied. After a steep decline, which started 2 - 4 h after the last meal, the 13CO2 
enrichment reached a plateau phase at 6 hours post-prandially. This plateau phase lasted for about 
6 - 8 h, suggesting steady-state glycogenolysis during this period. The plateau phase was followed 
by a further decline in 13CO2 excretion, suggesting a gradually diminishing contribution of 
13C-labelled 
liver glycogen to substrate oxidation. 
Conclusion  It is possible to label liver glycogen with a diet of naturally 13C-enriched carbohydrate. 
The oxidation of the labelled liver glycogen can be monitored by measuring 13C-enrichment in breath 
CO2.
Keywords 13C-enriched carbohydrate, 13CO2 breath test, hepatic glucose output,  glycogenolysis, 
liver cirrhosis, liver glycogen, stable isotopes.
Introduction
Liver glycogen is a readily available source of glucose for the maintenance of stable blood glucose 
levels between meals and during an overnight fast.
Impaired liver glycogen storage will result in a reduced contribution from glycogenolysis to the he-
patic glucose production during fasting. More energy will be supplied by free fatty acids. However, 
since adequate blood glucose levels are to be maintained, a reduced contribution from glycogen will 
result in an early-onset increase in gluconeogenesis and hence in increased proteinolysis. Recurrent 
proteinolysis for gluconeogenesis could result in muscle wasting and weight loss. This could be the 
case in patients with cirrhosis of the liver, especially if the protein intake is limited.1-3.
Recent studies have shown that patients with cirrhosis of the liver need ample protein intake to meet 
their higher protein requirements.2 It has also been shown that a late evening meal has a positive 
effect on the nitrogen balance.4 Nocturnal oral carbohydrate supplementation improves the nitrogen 
balance in patients with a cirrhosis of the liver. This phenomenon is not observed in healthy subjects.5 
This suggests that during an overnight fast in cirrhotic patients, with presumably a small liver glyco-
gen content, the liver glycogen is exhausted to such an extent that gluconeogenesis is enhanced. 
Nocturnal glucose supplementation could prevent this and reduce the proteinolysis. 
It would therefore be valuable to be able to measure the liver glycogen stores and to study glycogen 
kinetics in patients who are at risk for an early depletion of their liver glycogen. With such a method, 
the effects of nutritional intervention schemes could also be evaluated. However, at present, an easy 
and clinically applicable test to measure liver glycogen is not available.
In the past, glycogen concentrations have been measured in serial liver biopsies.6-8 Various catheteri-
zation techniques and indirect calorimetry have been used to study hepatic glucose output and sub-
strate oxidation.9-13 Recently, nuclear magnetic resonance (NMR), sometimes combined with isotopic 
A 13CO2 breath test for liver glycogen
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tracers, has been applied to study liver glycogen and liver glycogen kinetics.14-21 
These different techniques all have drawbacks for clinical application. Therefore we decided to study 
a model using 13C-enriched carbohydrate to label the liver glycogen pool and breath 13CO2 to monitor 
the oxidation of labelled carbohydrate. In this model the liver glycogen is (partly) depleted by a day of 
hypocaloric feeding and an overnight fast. Then, liver glycogen stores are refilled with 13C-enriched 
carbohydrate. Subsequently, during fasting, the appearance of 13CO2 in breath is measured to moni-
tor the utilization of the 13C-enriched liver glycogen. The aim of this study was to test the feasibility of 
this approach and to describe the pattern of the 13CO2 appearance in breath over time.
Materials and methods
Naturally 13C-labelled carbohydrate
In nature, the background abundance of the stable isotope 13C is about 1.1% of all carbon atoms. 
One would expect to find this abundance reflected in all carbon-containing macromolecules in plants 
too. However, this is not the case. There are two pathways in the photosynthesis of carbohydrates 
in plants, the C-3 and the C-4 pathway, leading to the production of carbohydrates with a different 
abundance of 13C. The difference in abundance is the result of a different degree of isotopic fractio-
nation in the two pathways.22 Carbohydrates formed via the C-3 pathway (Calvin-Benson cycle) have 
a relative low 13C abundance of 1.082%, whereas carbohydrates synthesized via the C-4 pathway 
(Hatch-Slack pathway) are relatively enriched in 13C with an abundance of 1.096%. In the human 
body, no isotopic fractionation takes place. This difference in natural 13C enrichment of carbohydrates 
can be exploited to study human glucose metabolism. 
Most plants used for human consumption are C3 plants. A few exceptions are corn, sugar cane, 
millet and pineapple, which use the Hatch-Slack pathway. In the European diet the main sources of 
carbohydrate are C3 plants. As a result, the 13CO2 abundance in breath in Europeans is relatively 
low. When such dietary C3 plant- derived carbohydrates are replaced by 13C-enriched carbohydrate, 
the body glycogen stores will become labelled with 13C-enriched glycogen. Fat and protein will not 
significantly become enriched on a C4 carbohydrate diet, which is given for five days or less.13 In 
short-term studies, therefore, 13C enrichment will only be found in the glycogen stores (muscle and 
liver). In other words, in the post-absorptive state the oxidation of 13C-enriched glycogen will be the 
source of 13C enrichment in CO2. Breath 
13CO2 excretion will than reflect the oxidation of 
13C-enriched 
glycogen.
The oxidation of muscle glycogen might interfere with a test in which the focus of attention is on the 
contribution of liver glycogen to glucose production.
However, during a short period of fasting, less than 24 h, muscle glycogen is hardly used in individu-
als who are at rest or performing light exercises.23-26
The combination of the selective 13C enrichment of the glycogen pools and the minimal use of muscle 
glycogen during an early sedentary fast establishes the conditions under which the 13C enrichment 
of exhaled breath reflects the use of 13C-enriched liver glycogen. We based our studies on this con-
cept.
Study groups
Twenty-four healthy volunteers participated in the study and followed a 3-day study protocol. For 
practical reasons the group of 24 healthy volunteers was split in 2 groups of 12 subjects, group 1 
and group 2. All participants habitually consumed a European, low 13C-abundance, diet. They did 
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not use any medication. All gave informed consent. The protocol was approved by the local ethical 
committee.
Group 1 
For each individual, the daily energy requirement was calculated using the Harris-Benedict formula. 
During day 1 of the study the subjects received 80% of their calculated energy requirement while 
they used their habitual low-13C diet. The figure of 80% was chosen assuming that glycogen would 
then not be fully replenished. A depletion of three-quarters of the pool is to be expected.27 Thus the 
liver glycogen pool would be sufficiently depleted during a subsequent overnight fast.
During day 2, the subjects consumed 120% of energy requirements as a naturally 13C-enriched car-
bohydrate diet, to ensure an ample refill of the liver glycogen pool with 13C-enriched carbohydrate. 
The composition of the diet is described below. 
The diet was consumed between 08.00 h and 22.00 h. This was followed by an overnight fast. 
During all 3 days, breath samples for analysis of 13CO2 enrichment were collected at the times indi-
cated in figure 1. No breath sampling took place during the night.
Group 2 
This group followed the same study protocol. However, there were a few differences. During day 2, 
the period of food intake was from 08.00 h till 18.00 h; mealtimes were strictly standardised. Breath 
samples were collected postprandially on day 2 and throughout the subsequent night till 09.00 h on 
day 3.
Fig. 1. Study protocol used for group 1, subject 1 - 12, and group 2, subject 13 - 24.
The empty boxes with an F represents the period of fasting. The striped boxes are the period 
during which each individual consumed 80% of their habitual diet. The crossed boxes are the 
period during which 120% of the naturally 13C-enriched diet was consumed. The  sign indicates 
the time when breath samples for 13CO2 analysis were collected.
A 13CO2 breath test for liver glycogen
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The 13C-enriched diet
The standard diet used during day 2 of the study consisted of 60% (w/w) carbohydrate, 27% (w/w) 
fat and 13% (w/w) protein. Eighty percent of the carbohydrate came from corn and sugar cane. The 
overall enrichment of the carbohydrate part of the diet was 1.0960 At% (atom per cent).
For breakfast, lunch and the late evening meal a pudding was consumed. This pudding was prepared 
from custard, a corn starch product (APJ bv, Koog a/d Zaan, The Netherlands), cane sugar, milk and 
cream. Dinner consisted of cooked polenta (milled corn, De Francescani, s.p.a. Monfalcone, Italy) 
with meat and vegetables. As “in-between”, cornflakes with milk and cane sugar were served.
Breath sampling
To obtain breath samples, alveolar air was collected in 20 mL vacutainer tubes. The rubber plug of 
the tube was removed and a drinking straw was inserted. After a normal inhalation, the subject qui-
etly exhaled through the straw. The straw was removed and the tube was quickly closed.
Analytical procedures
13CO2 enrichment in breath CO2 was measured using an Isotope Ratio Mass Spectrometer (SIRA-10, 
Series II, VG Isogas, Middlewhich, UK) fitted with an autosampler for the vacutainer tubes. Breath 
CO2 was isolated by condensation in a liquid nitrogen trap. Subsequently, the CO2 was released and 
led through the mass spectrometer. The measured isotope ratio was reported as percentage 13CO2, 
using a reference gas that was calibrated against the international PDB (Belemnitella americana) 
standard of 1.1235 Atom % 13C.
Calculations and statistics
For each subject, the baseline 13CO2 enrichment was calculated as the mean of the 12 individual 
observations on day one and expressed as At %. The increase in 13CO2 enrichment measured during 
day 2 and 3 was expressed in At% excess above baseline (APE). 
Group 1
For group one (subjects 1-12) the maximal enrichment at 08.00 h on day 3 was compared with the 
baseline enrichment. Then, for each individual, these data at day 3 were plotted over time and sub-
sequently a linear regression analysis was performed. The period between the time of last meal and 
the time the regression line reached baseline value was calculated. This “return to baseline time” is 
considered to reflect the time it will take before the liver glycogen pool is depleted of its 13C-labelled 
glycogen, i.e. the time after which no more net hepatic glucose production from 13C-labelled glycogen 
will take place.
Group 2 
For group two (subjects 13-24) the pattern of breath 13CO2 enrichment was studied in more detail dur-
ing day 2 and the subsequent night. This included the time of maximal enrichment, and the decline 
in enrichment occurring in the early postprandial hours and during the night.
The naturally 13C-enriched carbohydrates used for the diet of day 2 are easily absorbed by the gut.28 
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Therefore one may presume that the absorption of carbohydrate will be completed within 4 h after the 
last meal. As muscle glycogen has a minimal contribution to glucose production and oxidation during 
sedentary conditions, the only source of enriched 13CO2 will be liver glycogen from 4 h postprandially 
onwards.
To determine the contribution to glucose production from the liver 13C glycogen pool, we corrected 
our data for the 13C enrichment of the CO2-pool at 4 h post-prandially. When no further production of 
13CO2 could take place, the 
13CO2 enrichment would decline as described by the 
13CO2 elimination 
curve. This curve was applied to the 4-h post-prandial data. The calculated elimination curve was 
subtracted from the measured data curve. The resultant curve reflects the 13CO2 actually being pro-
duced and entering the CO2-pool from 4 hours postprandially onwards. Under the given conditions, 
this 13CO2 originates from the 
13C-enriched liver glycogen pool.
For this purpose, the CO2 pool was considered to be one compartment, and a half-life time of the 
label in the CO2 pool of 60 minutes was assumed (k=0.0115).
13,29  An elimination curve was then 
constructed using the equation
APEt2 = APEt1x e
-0.0115 x (t2-t1)
In this equation t is the time expressed in minutes and t1 is 4 h after eating.
When applicable the Studentʼs t-test was used for paired or un-paired data. A P ≤ 0.05 was consid-
ered to be significant.  
Results
The characteristics of the 24 participants are shown in Table 1.
Group 1
The mean basal breath 13CO2 enrichment at day 1 for group 1 was 1.0827 At% (SD 0.0004). The 
13C-
enrichment (Table 2) increased with 0.0041 APE (SD 0.0006) during day 2 (P < 0.001). At day 3 the 
mean 08.00 h value was 0.0022 APE (SD 0.0006) which differed from the basal value (P < 0.001), as 
well as from the maximal APE observed during day 2 (P < 0.001).
A linear decline in 13C-enrichment was observed during day 3. The mean time of return of breath 13C-
enrichment to baseline values was 20.3 h after the last meal (SD 3.2 ; r2 = 0.98, Fig.2) with a range 
from 16.5 till 27.0 h (Table 2).
Group 2
For group 2, the mean basal 13CO2 enrichment was 1.0820 At% (SD 0.0006). This value did not dif-
fer from the fasting value at day 2 (at 08.00 h), which was 1.0821 At% (SD 0.0004). During day 2, 
while the naturally 13C-enriched carbohydrate diet was consumed, the 13C-enrichment of breath CO2 
increased to a maximum of 0.0048 APE (SD 0.0010). This maximum was reached at a mean of 160 
minutes (SD 59) after the last meal. (Fig. 3)
The influence of the 3 main meals is clearly visible in the 13CO2 enrichment profile.
The measured individual postprandial data are shown in Fig.  4. This graph also shows the theoreti-
cal 13CO2 wash-out curve 4 hours after the last meal and onwards, as well as the constructed curve 
describing breath 13CO2 excretion from 
13C-glycogen-derived and subsequently oxidised glucose. 
The resultant curve indicates a plateau phase of 13CO2 appearance during the night. This plateau is 
followed by a decline resembling the pattern of excretion of 13CO2 found in the group 1.
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Table 1. Particulars of the study group.
                                                                                       
 Group 1       Group 2
     sex age weight  height  BMI |     sex   age weight  height  BMI
   in kg. in cm. kg/m¯2 |  in kg. in cm. kg/m¯2
    1  F 20 60 173 20.0 | 13  M   48  78 178 24.6
    2  F 20 69 167 24.7 | 14   F   44  72 172 24.3
   3  F 47 58 165 21.3 | 15  M   36  83 191 22.8
   4  F 20 60 175 19.6 | 16   F   35  73 167 26.2
   5  F 44 61 176 19.7 | 17  M   29  75 197 29.3
   6  F 19 60 178 18.9 | 18   F   30  69 172 23.3
   7  F 59 66 167 23.7 | 19  M   33  80 178 25.3
   8  F 22 73 185 21.3 | 20   F   32  63 167 22.6
   9 M 20 74 183 22.1 | 21   F   42  63 175 20.6
 10 M 20 80 180 24.7 | 22  M   42  96 189 26.9
 11 M 51 90 189 25.2 | 23  M   33  88 186 25.4
 12 M 53 70 175 22.9 | 24   F   32  67 171 22.9
 mean 32.9 68.4 176.1 22.0 |mean 36.3  75.6 178.6 23.7
 sd 16.2   9.7     7.5   2.2 |sd   6.1  10.0     9.9   2.2
Table 2  Group 1, basal 13CO2 abundance, maximum 
13CO2 enrichment, 
13CO2 enrichment 10 
hours postprandial, the postprandial time period before baseline values are reached again and 
the r2 of the individual regression analysis of the return to baseline time. 
 Subject day1  day2  day3  return to  regression
  baseline  maximum 8.00am  baseline   line 
  abundance enrichment enrichment time           
  AP      APE      APE   (h)   (r2))
     1 1.0833  0.0041  0.0017  19.0  0.78
     2 1.0827  0.0048  0.0025  18.8  0.96
     3 1.0825  0.0043  0.0015  27.0  0.65
     4 1.0824  0.0041  0.0015  18.7  0.88
     5 1.0825  0.0045  0.0029  19.8  0.92
     6 1.0832  0.0045  0.0017  26.7  0.76
     7 1.0827  0.0046  0.0022  19.4  0.82
     8 1.0829  NA         0.0016  20.6  0.80
     9 1.0827  0.0032  0.0022  19.2  0.97
   10 1.0823  0.0044  0.0035  19.0  0.78
   11 1.0828  0.0030  0.0021  19.3  0.89
   12 1.0831  0.0039  0.0027  16.5  0.91
 mean 1.0828  0.0041a  0.0029b  20.3
 SD 0.00045  0.00057  0.00063      3.19
Basal abundance expressed in atom percent (AP), enrichment in atom percent excess relative to 
baseline values (APE) and return to baseline time in hours. a Significantly different from baseline 
abundance (p<0.001) b Significantly different from baseline abundance (p<0.001) and from maxi-
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mum enrichment day 2 (p<0.001). NA = not available
The average enrichment during the plateau phase was 0.0020 APE (SD 0.0007). The end of the 
plateau phase was estimated for each individual and a mean of at least 13.5 h after the last meal 
was observed. (n=10) In two subjects the end of the plateau was not reached within the observation 
period.
Fig. 2. The hourly mean (±SD) and the regression line of the 13CO2 enrichment in breath of 
group 1 in the postprandial phase during day 3 of the experiment.
Fig. 3. The mean 13CO2 enrichment (±SD) in breath samples of group 2 during day 2 and 3 of the 
experiment. During day 2 a 13C-enriched diet was consumed. Breakfast, lunch and dinner are 
indicated by an arrow, I . From 6 pm onwards all subjects were fasting till 9 am on day 3.
Time zero, 6 pm day 2, is the time when the last meal was consumed. 
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Fig. 4. The 12 individual curves of the participants of group 2 showing the 13CO2 enrichment 
from the moment the last meal at day 2 till the end of the experiment at 9 am on day 3. The 
continuous lines with the open square markers (◊) show  the measured data. The dotted lines 
with the filled dots (•) are the calculated 13CO2 elimination curves from 4 hours postprandial. The 
interrupted lines with the filled square markers (   ) are the resultants of the subtraction of the 
elimination curves from the measured data, reflecting the oxidation of carbohydrates derived from 
13C-enriched glycogen.
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Discussion
The 13C-enrichment of carbohydrates formed by C4-plants, such as corn and sugar cane, is slightly 
but consistently higher than in other plants. This can be exploited by using their carbohydrate in clini-
cal research. 
In 1973, Lacroix et al.30 reported on the use of such naturally 13C-enriched glucose in combination 
with 13CO2 breath analysis. They demonstrated that a glucose tolerance test carried out with naturally 
13C-enriched glucose produces reproducible 13C-enrichment in breath CO2. Since that time this ap-
proach has been used to study different aspects of the glucose metabolism in man.28,31-34
Recently, a naturally 13C-enriched carbohydrate diet was used to label the liver glycogen pool in a 
study with the aim of determining the contribution of gluconeogenesis to total endogenous glucose 
production and hepatic glycogen renewal.13 In that study, 13CO2 breath analysis and plasma 
13C-
glucose levels were measured under post-absorptive conditions. In our study, we used a similar 
approach to label the liver glycogen pool with naturally 13C-enriched carbohydrate. We, however, 
focussed specifically on the possibility of monitoring glycogenolysis in the post-prandial state. To this 
end the 13C enrichment of breath CO2 was used as a parameter for the oxidation of 
13C-labelled liver 
glycogen-derived glucose.
The concept of our study is based on two assumptions. First, fat and protein should not be 13C 
enriched but should have the same 13C abundance as the baseline 13C abundance of glycogen. 
Moreover this abundance in fat and protein should not change during the use of the 13C-enriched 
carbohydrate diet. A study comparing the 13C-abundance of fat (VLDL) and protein (plasma protein) 
before and after a 5-day diet with naturally 13C-enriched carbohydrate showed no increase in 13C-
enrichment of fat and protein over this period.13 However, when a 13C-enriched carbohydrate diet 
is given for a much longer period or is continuously used as a standard diet, the large pools of fat 
and protein will become 13C-enriched too. Rats fed only with 13C-enriched carbohydrate for 35 days 
showed a 13CO2 enrichment which equalled the 
13C-enrichment of the consumed carbohydrate.31
Owing to the short duration of our protocol, no interference of labelled proteins or lipids is expected.
The second assumption is that there should not be a significant contribution of muscle glycogen to 
glucose oxidation during the post-absorptive resting state.
It has been established that at rest and during conditions of low-level exercise the main energy 
substrates oxidized by muscle cells are free fatty acids and blood glucose.24-26,35 They are used in 
preference to the available glycogen in muscle glycogen.23-25,35
Studies on the influence of diet on muscle glycogen stores, using muscle biopsies, showed that total 
starvation over a period of 1 day had very little effect on the glycogen stores, provided the subjects 
were at rest.23,37 In the resting muscle, glycogenolytic activity is extremely low38 and muscle glycogen 
is only to be used when more than light exertion is demanded from the muscle.23,24,35
During low-intensity exercise while fasting, muscle energy comes from blood glucose and  free fatty 
acids but not from muscle glycogen.24,35
Although repletion of the depleted muscle glycogen stores occurs at a very low rate during starvation, 
rapid synthesis of glycogen takes place on a carbohydrate-rich diet. The latter process is restricted 
to depleted muscles only.39 Thus during a sedentary fast, the muscle glycogen pool is not very active 
metabolically.
These observations lead us to conclude that the contribution of glucose from muscle glycogen to 
substrate oxidation is very low during a sedentary fast.
Recently, we demonstrated that a higher muscle glycogen 13C-enrichment does not interfere with the 
determination of liver glycogen depletion.40
We conclude that during a sedentary fast the 13C-enrichment in breath CO2 is a parameter of the 
oxidation of 13C-labelled liver glycogen.
In our study the basal 13CO2 abundance in breath confirmed the low 
13C abundance of the habitual 
(Western-European) diet used by the volunteers.30,32 There was no difference between the 13CO2 
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abundance in breath measured at different times during a whole day (day 1) and the 08.00 h (fasting) 
values measured on  the second study day.
Cahill and Owen27 calculated that the liver glycogen stores would be exhausted after 18 - 24 hours of 
fasting. Serial liver biopsies in men showed a decline from 232 to 42 mmol glycosyl units per kilogram 
wet liver tissue between 12 and 36 h of fasting. The maximum postprandial concentration in that 
study was 503 mmol glycosyl units per kg wet liver. During a longer period of fasting, up to 10 days, 
the glycogen concentration of the liver remained at this low level.7 NMR studies showed a decrease 
of liver glycogen to 16% of the initial content after 40 h of fasting. During fasting, the liver decreases 
in size. Taking this into account, 16% could even be an overestimate.14 These data show that liver 
glycogen content decreases substantially during fasting. Moreover, they indicate that liver glycogen 
is not totally exhausted even during prolonged fasting, but that low concentrations remain. We ob-
served that breath 13CO2 enrichment returned to baseline values at approximately 20 h after the last 
meal. This indicates that the contribution of the 13C-labelled liver glycogen to substrate oxidation had 
diminished to an undetectable level.
Presuming an evenly mixed distribution of 13C-enriched glycogen throughout the whole liver, this im-
plies that the whole liver glycogen pool is reduced to a minimal level and that the net hepatic glucose 
production from hepatic glycogen is low. We believe this to be a realistic result, because the time 
period of 20 hours in which the breath 13CO2 enrichment reaches baseline values is rather congruent 
with the findings in the literature. Indeed, after a period of about 22 h, gluconeogenesis accounts for 
70% of the glucose production.14,41,42
After we found that it is possible to use the naturally 13C enriched diet to label liver glycogen and to 
come to a plausible “liver glycogen depletion time” in the first experiment (group 1), we studied the 
pattern of 13CO2 enrichment in breath in more detail in a second group of volunteers (group 2). In 
this group, a steep rise in breath 13CO2 enrichment was observed after breakfast followed by a more 
gradual increase. Lunch and dinner were reflected by an accelerated increase in breath 13CO2 output 
(Fig. 3).
In our study, no information could be obtained about the net hepatic glucose production in the first 4 
hours postprandially when gut-derived glucose was readily available for oxidation. However, after 4 
hours, when gut glucose absorption has been completed, glucose supply comes from hepatic gly-
cogenolysis and gluconeogenesis. Therefore, we constructed our theoretical 13CO2 wash-out curve 
starting at 4 h post-prandially. Taylor et al.20 reported a down-regulation of the hepatic glucose output 
to almost zero during the first hours postprandially. This down regulation was followed by a gradual 
increase of hepatic glucose output until a plateau was reached at 6 hours postprandially.
We observed a plateau in breath 13CO2 enrichment that started at 6 hours after the last meal and 
continued until 12 - 14 h postprandially in 10 of the 12 subjects. In the other two, the plateau lasted 
beyond the observation time of 15 hours. This plateau phase indicates a steady state in 13C-labelled 
carbohydrate oxidation during this period. This is interpreted as a constant rate of liver glycogen con-
sumption. Such a linear use of liver glycogen was found by NMR studies as well.14,20
The decline in breath 13CO2 observed at the end of the plateau phase reflects a reduced contribution 
of 13C-labelled carbohydrate to oxidation. In other words, at this time a change in energy sources 
used for oxidation seems to occur. We speculate that at this time the process of gluconeogenesis is 
accelerating.
Because in our second series of experiments the observation time was limited to 15 hours, and the 
breath 13CO2 enrichment did not return to baseline values in that time frame, insufficient data were 
available to calculate for each individual a time of return to baseline 13CO2 values. Therefore we ap-
plied the formula derived in our first study group to the collective data of the second group. The result 
was a mean postprandial time of return to baseline 13C-enrichment of 19.0 (SD 1.79, n=10) h. This is 
in line with the results that were obtained in the first group.
After we observed the plateau phase in the second experiment (group 2), we re-examined the group 
one data to see whether retrospectively a plateau phase in 13CO2 excretion might also be discernible. 
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Indeed in subject 3 and 6 the 13CO2 enrichment curve is initially flat; this could indicate the end of a 
plateau phase. For those two individuals a regression line was calculated starting at the end of the 
plateau phase. As a result we found a return to baseline in 21.9 hours ( r2=0.97) in subject 3 and in 
21.3 hours (r2=0.98) in subject 6 instead of the earlier calculated 27.0 hours (r2=0.65) and 26.7 hours 
(r2=0.76). These results are more in line with the data of the other 10 subjects of group 1. (Table 2)
Gay et al.13 showed that the maximal 13C-enrichment in glycogen was reached after 3 days of using 
the 13C-enriched diet. In our protocol with only one day of 13C-labelling of the liver glycogen pool it is 
unlikely that a maximal 13C-enrichment in glycogen was achieved. However, as long as the 13C-label 
is evenly mixed throughout the liver glycogen pool, the lower degree of 13C-enrichment will not inter-
fere with the outcome of our study. 
The issue of an even distribution of 13C-label is of importance in the interpretation of the data. One 
might wonder whether newly synthesised glycogen will be deposited at the periphery of the glycogen 
macromolecule and will be mobilized in preference to already existing glycogen. In such a situation, 
the 13C-enrichment will not be representative for all glycogen. This would lead to a false estimation of 
exhaustion of the liver glycogen pool in our study design.
We think that a more even distribution of label will take place. The glycogen molecule is spherical and 
consists of concentric tiers of branched and unbranched chains. The configuration of the molecule is 
such that the amount of glucose directly available to be released by phosphorylase is about 35% of 
the total molecule.43,44 Owing to the concurrent processes of glycogen synthesis and glycogenolysis 
and the inherent exchange of labelled and unlabelled molecules during this process, a fair mix of 
13C-enriched glycosyl units throughout the macromolecule can be expected, especially if a substan-
tial part (more than three-quarters of the total) of the glycogen granules has been used before the 
enriched diet started. To achieve this, the subjects in our study used a hypocaloric diet during the 
first day of the experiment. Altogether, it seems reasonable to assume a fair distribution of the 13C-
enriched glycosyl units throughout all glycogen particles.
In conclusion, after the liver glycogen pool is labelled with naturally 13C-enriched carbohydrate, it 
is possible to obtain a degree of enrichment that is sufficient for it to be used in a test where liver 
glycogen consumption is measured through breath testing for 13CO2 excretion. During an overnight 
fast under sedentary conditions a steady state exists in glycogenolysis for about 10 h, starting from 
4 h post-prandially. Subsequently, a period of gradual decrease in breath 13CO2 enrichment follows 
this plateau phase. This is compatible with a shift from glycogenolysis to gluconeogenesis during 
that time. 
This easily applicable, non-invasive method could be a tool to study liver glycogen mobilisation in 
healthy subjects and in patients with liver disease. However, further studies are needed first to vali-
date the method.
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4.2
Muscle glycogen does not interfere with a 13CO2 breath test 
to monitor liver glycogen oxidation
A. A. Tanis, T. Rietveld, J. L. D. Wattimena, J. W. O. van den Berg 
and G. R. Swart.
Clinical Physiology 2000;20:126-133
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Summary
Naturally 13C-enriched carbohydrate has been used to label the liver glycogen pool for metabolic 
studies. The utilisation of this glycogen was then monitored by the appearance of 13CO2 in breath. 
Using this method, it is assumed that during sedentary fasting the contribution of muscle glycogen 
towards oxidation is negligible. We investigated the influence of a different level of 13C enrichment 
of muscle glycogen on the 13C enrichment of breath CO2 while the breath test was carried out. In six 
healthy volunteers the muscle glycogen stores were grossly depleted by a cycling exercise prior to 
the consumption of the 13C-enriched diet which was given over a 10 h period. The oxidation of liver 
glycogen was measured during an 18 h sedentary fast. The results were compared with a control 
group who had not depleted their muscle glycogen before labelling. A higher 13C enrichment of mus-
cle glycogen did not interfere with two parameters of liver glycogen oxidation i.e. the duration of the 
plateau phase of 13CO2 and the return to baseline time. It was also shown that the 
13C-labelled muscle 
glycogen was still available after the 18 h fast because a strenuous exercise led to a rapid 13CO2 
enrichment. It is concluded that muscle glycogen 13C enrichment does not invalidate a 13CO2 breath 
test to measure liver glycogen oxidation during a sedentary fast.
Keywords 
13CO2 breath test, fasting, muscle exercise, naturally 
13C-enriched carbohydrate, stable isotopes.
Introduction
Recently we described a new non-invasive method to monitor liver glycogen oxidation during fast-
ing. The purpose of the used technique was to design a method, which would be easily applicable in 
the clinic. With such a tool, patients at risk for early depletion of their liver glycogen stores could be 
identified and effects of nutritional intervention could be evaluated.
In this method, body glycogen stores are labelled by means of a diet containing naturally 13C-
enriched carbohydrate derived from corn and cane sugar. Part of the 13C-enriched carbohydrate will 
be used for glycogen synthesis in liver and skeletal muscle.
In the postprandial phase, this 13C-labelled glycogen is mobilized and oxidized, the 13C enrichment of 
the CO2 pool will increase. This increase can be measured in breath CO2. Since during fasting under 
sedentary conditions muscle glycogen is hardly oxidized, the measured increase in 13C enrichment 
of CO2 under those conditions derives from liver glycogen oxidation (Tanis et al. 1998).
The assumption that during fasting under sedentary conditions muscle glycogen is hardly oxidized 
is based on various biopsy and isotopic tracer studies. (Andres et al. 1956; Hultman & Bergstrom, 
1967; Romijn et al. 1993; Hultman et al. 1994; Coyle, 1995; Felber & Golay, 1995). Other studies 
showed that as long as subjects are at rest, a one-day total starvation has little effect on muscle gly-
cogen stores (Andres et al. 1956; Loy et al. 1986) and glycogenolytic activity is very low (Chasiotis, 
1983). Under those circumstances skeletal muscles use free fatty acids and blood glucose as sub-
strates (Romijn et al. 1993; Hultman et al. 1994; Coyle, 1995; Felber & Golay, 1995).
Gay et al. (1994) reported that the 13C enrichment of body fat and protein does not increase during a 
few days diet with naturally 13C-enriched carbohydrate.
Combining these findings, we concluded that the increase in 13C enrichment of breath CO2 is a pa-
rameter for the oxidation of glucose derived from liver glycogen and not of muscle glycogen, provided 
the subject is sedentary during a 24-hour period of fasting.
We decided to test this assumption. This was done by comparing the 13CO2 breath test in persons 
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with a low and a high 13C enrichment of their skeletal muscle glycogen. A high 13C enrichment of 
skeletal muscle glycogen was achieved by the consumption of a naturally 13C-enriched carbohydrate 
diet shortly after the study subjects grossly depleted their skeletal muscle glycogen stores through a 
short period of intensive exercise.
The control group followed the same protocol but did not exercise before the 13C-enriched diet and 
hence had a lower 13C enrichment of the skeletal muscle glycogen.
The aim of this study was to test the hypothesis that the degree of 13C enrichment of muscle glycogen 
will not interfere with the measurement of mobilisation of liver glycogen during a period of a sedentary 
fast.
Methods
Twelve healthy volunteers participated in the study. Their usual diet was of a low 13C abundance, the 
typical West-European diet, with carbohydrates derived from C3-plants (Lefèbvre, 1985).
All subjects followed a three-day study protocol as shown in Fig.1. Details of this protocol have been 
described previously (Tanis et al. 1998). In short, all participants used their habitual diet during day 
1. The caloric intake was 80% of the calculated caloric requirements. (Harris-Benedict, light duties) 
This hypocaloric intake was chosen to ensure a sufficient depletion of the liver glycogen stores on 
the morning of day 2 after an overnight fast.
On day 2, breath samples were taken to determine basal 13C abundance in breath CO2.
In six subjects (the cycling group), depletion of the muscle glycogen pool was attained by a 30 min 
cycling exercise at 80% of the calculated maximal exercise capacity. Vital signs (blood pressure, 
heart rate, respiration rate and blood O2 saturation) were monitored during this period. After the ex-
ercise, breath samples were collected and a diet containing naturally 13C-enriched carbohydrate was 
consumed. This diet provided 120% of calculated caloric requirements. Subsequently the subjects 
fasted for 18 h under sedentary conditions. 
Six subjects served as control group. They followed the same protocol, but they did not exercise and 
they fasted for 24 h.
During the entire observation period of eating and fasting, breath samples for 13CO2 enrichment 
analysis were taken in both groups at regular intervals.
At the end of the sedentary fasting period, a second cycling exercise, identical to the first one, was 
performed in the cycling group.
The naturally 13C-enriched carbohydrate diet
The 13C-enriched diet used during day 2 of the study consisted of 60% (w/w) carbohydrate, 27% fat 
and 13% protein. Eighty percent of the carbohydrate came from corn and sugar cane. The 13C enrich-
ment of the carbohydrate in the diet was 1.096 At%.
For breakfast and lunch, a pudding was consumed, prepared from custard. (A corn starch product, 
APJ bv, Koog a/d Zaan, The Netherlands), cane sugar, milk and cream. Dinner consisted of cooked 
polenta (milled corn, De Francescani, s.p.a. Monfalcone, Italy) with meat and vegetables. In be-
tween, cornflakes with milk and cane sugar were consumed.
Breath sampling
Alveolar air samples were collected in 20ml vacutainer tubes (Becton Dickinson Vacutainer Systems 
Europe, Plymouth, UK). The rubber plug of the tube was removed and a drinking straw was inserted. 
After a normal inhalation, the subject quietly exhaled through the straw. The straw was then removed 
and the tube was quickly closed.
Analytical procedures
13CO2 enrichment in breath CO2 was measured using an Isotope Ratio Mass Spectrometer (SIRA-10, 
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Series II, VG Isogas, Middlewhich, UK) fitted with an autosampler for the vacutainer tubes. Breath 
CO2 was harvested by condensation in a liquid nitrogen trap. Subsequently the CO2 was released 
and led into the mass spectrometer. The measured isotope ratio was reported as percentage 13CO2. 
As reference was used a calibrated CO2 gas, that was standardised against the Pee Dee Belemate 
limestone value of 1.1235 Atom %.
Figure 1. Study protocol used for the control group and the cycling group. The empty boxes with 
an F represent the period of fasting. The striped boxes are the period during which each individu-
al consumed  their habitual diet. The crossed boxes are the period during which the naturally 13C-
enriched diet was consumed. Breath samples for 13CO2 analysis were collected at the indicated 
times. The cycling group performed a 30 minutes cycling exercise at the time indicated by a C.
Calculations and statistics
For each subject, the baseline 13CO2 abundance on day 2 was calculated as the mean of two fasting 
observations at the start of that day. The increase in 13CO2 enrichment measured during day 2 and 3 
was then expressed in atom percentage excess 13C above baseline (APE).
The breath 13CO2 enrichment is the result of the two simultaneous processes of production and 
elimination. The elimination of 13CO2 follows the half-life time of the CO2 pool. Since the half-life time 
is 60 min (Meineke et al. 1993), the first-order rate constant related to the half-life of the process (k) 
is 0.0115 (time in min-1). Using this constant, an elimination curve can be constructed by application 
of the equation 
APEt2 = APEt1x e
-0.0115 x (t2-t1)
Assuming that carbohydrate absorption from the gut is completed 4 h after the last meal, the ap-
plication of this equation to the enrichment of 4 h postprandial ( t1) predicts an elimination curve for 
the 13CO2 which is present in the CO2 pool at that very moment. We subtracted the elimination curve 
thus calculated from the measured data. The resultant curve reflects the 13CO2 actually produced 
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and entering the CO2 pool. Since the liver glycogen pool will be the only pool supplying 
13C-enriched 
carbohydrate under sedentary conditions, the resultant curve will reflect the contribution of labelled 
liver glycogen towards glucose production and oxidation.
During the night, a plateau phase in 13CO2 enrichment can be observed. (Tanis et al, 1998) The level 
of enrichment at plateau level, the duration of the plateau phase and the subsequent decline in 13CO2 
enrichment were used for analysis. The plateau phase is defined by the average 13CO2 enrichment of 
the data measured between 7 and 12 hours postprandial. The end of plateau phase was determined 
by the point in time at which a consistent decline of 13CO2 enrichment of more than 10% started. The 
decline was considered consistent if for at least two measuring points the following measurement 
showed a lower enrichment than the previous one.
The data from this time point and onwards were used for a linear regression analysis. The time at 
which the regression line crossed the horizontal axis was calculated and considered as the return to 
baseline time (RTBT).
The maximum rise in 13CO2 enrichment, which occurred after the second cycling session, was com-
pared with the 13CO2 enrichment data at the start of that session.
Studentʼs t test was used for paired and unpaired data. A P ≤ 0.05 was considered to be significant.
Table 1. Particulars of the control group and the cycling group.
     
 control group    | cycling group
      |
      |
      |
 sex age height weight BMI |  sex age height weight BMI
      |
  yr cm kg kg/m2 | yr cm kg kg/m2
      |
      |
 M 26 182 70 21.1 |  F 24 181 66 20.1
      |
 M 24 177 64 20.4 |  F 23 176 56 18.1
      |
 M 23 174 74 24.4 |  M 29 185 78 22.8
      |
 M 25 172 64.8 21.9 |  M 24 170 74 25.6
      |
 M 22 198 87 22.2 |  F 23 173 62 20.7
      |
 F 24 169 58.5 20.5 |  M 22 184 64 18.9
      |
      |
      |
 mean 23.9 178.7 69.7 21.8 | 24.2 178.2 66.7 21.0
      |
 sd   1.4   10.5 10.0   1.5 |   2.48     6.11   8.07   2.76
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Results
The cycling group consisted of three women and three men, and the control group of five men and 
one woman (Table 1).
The mean basal 13CO2 enrichment measured during day 1 was 1.0816 Atom% (SD 0.0007) in the 
cycling group as compared to 1.0821 Atom% (SD 0.0003) in the control group (not significant). 
After the first cycling session in the cycling group no rise in 13CO2 enrichment was observed: -0.0008 
Atom% (SD 0.0005) pre-cycling versus 0.0002 Atom% (SD0.0006) post-cycling, (not significant).
As soon as the 13C-enriched diet was started the breath 13CO2 enrichment rose briskly to a maximal 
mean value of 0.0061 APE (SD 0.0013) 1 h and 15 min (SD 15 min) after the last meal. The mean 
maximal value in the control group was 0.0059 APE 2 h and 12 min (SD 72 minutes) after the last 
meal. The difference was not significant. 
The mean rise in enrichment at plateau level was 0.0025 APE (SD 0.0012) for the cycling group and 
0.0026 APE (SD 0.0005) for the controls (not significant). 
The end of the plateau phase was observed at 13.6 h postprandial (SD 0.86) in the cycling group as 
compared with 12.8 h (SD 1.17) in the control group (not significant)
In the cycling group the mean return to baseline time following the plateau phase was 19.7 h post-
prandial (SD 3.32) and 22.9 h (SD 2.45) in the control group (not significant)
A second cycling session was carried out to analyse the 13C enrichment in muscle glycogen at the 
end of the fasting period. The mean 13CO2 enrichment at the start of this second cycling session was 
0.0011 APE (SD 0.0013). After 30 min of cycling, the 13CO2 enrichment increased significantly to a 
mean of 0.0038 APE (SD 0.0019, P < 0.001), (Figs 2 and 3).
The top of the enrichment curve was 0.0040 APE (SD 0.0017) 54 min (SD 22 min) after the second 
cycling session.
In a pilot study 4 subjects followed the same protocol as the control group (i.e. no exercise before the 
diet started). However they performed a 30 min cycling exercise after 11 h of fasting and repeated 
this 2 h later. In this group, a small and repeatable temporary decrease in 13C-enrichment in breath 
CO2 occurred after each cycling period. (Fig. 4). This suggests a dilution of 
13CO2 by lower enriched 
CO2 from muscle glycogen oxidation.
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Figure 2. The mean 13CO2 enrichment (±SD) in atom percent excess in breath samples of the 
control group and the study group during day 2 and day 3 of the experiment. During day 2 the 
special 13C-enriched diet was consumed. The time at which the meals were taken are indicated 
by a M. Time zero, 18.00h day 2, is the time when the last meal was consumed. The time of the 
two cycling exercises in the cycling group are presented by a C.
Figure 3. The mean 13CO2 enrichment in atom percent excess of the control group and the cycling 
group from the time the last meal was consumed. The continuous line with the filled dots (●) are 
the measured data. The dotted line with the open triangles (∇) are the calculated 13CO2 elimi-
nation curves from the 4 hours postprandial data. The broken lines with the open dots (O) are 
the resultants of the subtraction of the elimination curves from the measured data, reflecting the 
oxidation of carbohydrate derived from 13C-enriched glycogen. The straight line is the regression 
line of the data following the plateau phase. The arrow points at the return to baseline time. The 
time of the second cycling exercise in the cycling group is indicated by a C.
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Figure 4. The breath 13CO2 enrichment in atom percent in one of the four individuals, who followed 
the same protocol as the control group with the exception that they performed a cycling exercise 
11 and 14 hours after the last meal. A C with arrow indicates the times of the cycling exercises. 
Discussion
Recently we described a method to monitor the utilisation of liver glycogen for energy production with 
a breath test (Tanis et al. 1998).
With this method the glycogen pools are labelled with naturally 13C-enriched carbohydrate. 
Subsequently during a sedentary fast the rise in 13C enrichment in breath CO2 reflects the oxidation 
of 13C-labelled glucose, which is under those circumstances derived from liver glycogen. This method 
is based on the concept that muscle glycogen is hardly, if at all, utilised as long as muscle exercise 
is avoided during the test procedure (Andres et al. 1956; Hultman & Bergstrom, 1967; Romijn et al. 
1993; Hultman et al. 1994).
In the present study, we elaborated on this assumption by testing the potential contribution of muscle 
glycogen to the CO2 production. Through a short period of strenuous exercise the skeletal muscle 
glycogen depots were grossly depleted. Thereafter muscle glycogen was repleted with naturally 
13C-enriched glucose. Starting from this situation we tested whether the higher muscle glycogen 13C 
enrichment interfered with the measurement of liver glycogen utilization. 
The baseline 13C abundance in both the cycling and the control group was at the (low) level expected 
for persons used to a West-European diet (Lacroix et al. 1973; Schoeller et al. 1980). No rise in 13CO2 
was observed after the first cycling period before the 13C-enriched diet was started. This confirms that 
the muscle glycogen pool, which was mobilised as soon as such strenuous exercise was started, 
had the same low 13C abundance as the other energy sources (liver glycogen, fat and protein) which 
contributed to the baseline 13CO2 production. 
A similar low 13C abundance of the different energy sources in the body has been reported earlier in 
West-Europeans (Wagemakers et al. 1993). 
The subjects in the cycling group performed at 80% of their VO2max. It is well known that during 
such a degree of exercise muscle glycogen is utilized to a large extent (Bergstrom & Hultman, 1966; 
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Romijn et al. 1993). Repeated muscle biopsies to measure the degree of 13C enrichment of the glyco-
gen and to verify the degree of skeletal muscle glycogen depletion would have provided more direct 
information. However, for practical reasons, this was not done.
Shortly after the first cycling session, the intake of the naturally 13C-enriched carbohydrate food 
started. Due to immediate oxidation of some of the just absorbed 13C-enriched glucose, the breath 
13CO2 increased as soon as the diet was started. The diet contained enough carbohydrate to ensure 
an adequate repletion of the glycogen pools. It has been established that the muscle glycogen syn-
thesis is indeed increased after a short high-intensity exercise. Such an increase is much higher than 
that after a prolonged resistance exercise (Pascoe & Gladden, 1996). It may therefore be assumed 
that by the end of day 2 the muscle glycogen pool of the subjects in the cycling group had a higher 
13C enrichment then in the control group.
A substantial part of the energy that is needed for moderate to intensive exercise comes from an 
increased utilisation of liver glycogen (Romijn et al. 1993; Hultman et al. 1994). Consequently, one 
could speculate that the liver glycogen pool would be more depleted after the first exercise session 
as compared with the liver glycogen pool of the control group. Repletion by 13C-enriched glycogen 
could result in a higher overall 13C-enrichment of the liver glycogen pool. However, this was not ob-
served, since the plateau enrichment did not differ between the two groups.
Two conclusions can be drawn from this observation. The first conclusion is that a higher 13C enrich-
ment of the skeletal muscle glycogen pool does not interfere with the measurement of the process 
of liver glycogen depletion. The rise of 13CO2 directly after the second cycling session confirmed that 
the muscle glycogen was still 13C-enriched at that time. These results certainly provide a strong indi-
cation that under sedentary fasting conditions the breath test measures selectively the mobilisation 
of (13C-labelled) liver glycogen and not muscle glycogen. The repeatable decrease in breath 13CO2 
enrichment after a strenuous cycling exercise in subjects who otherwise followed the same protocol 
as the control group (Fig. 4) indicates a dilution of 13CO2 by lower enriched CO2 from muscle glycogen 
oxidation. Thus no significant degree of 13C-labelling of muscle glycogen took place in those individu-
als, who had not depleted their muscle glycogen stores through muscle exercise before they started 
the 13C-enriched diet. Otherwise an increase in 13CO2 exhalation would have been obtained, as was 
observed in the present study.
Secondly, we created a situation that led to a higher 13C enrichment of muscle glycogen. This labelled 
glycogen is presumably conserved in the muscle as long as the study subject is sedentary. We 
observed a steep increase of 13C enrichment of breath CO2 as soon as the second cycling session 
started. Although no quantitative data were obtained, this certainly proves that under fasting condi-
tions a substantial amount of muscle glycogen was preserved and can be used during exercise. It 
could be argued that the rise of 13CO2 after the second cycling session was caused by an increased 
oxidation of labelled liver glycogen. However, the decline in 13CO2 in cycling persons with a low 
13C 
muscle glycogen enrichment argues against this (Fig. 4).
In summary, we studied the effect of a higher degree of 13C enrichment of liver and muscle glycogen 
on the results of a 13CO2 breath test, which was designed to monitor the utilization of liver glycogen. 
While using test conditions with a different degree of 13C-labelling of muscle glycogen, no difference 
was observed in plateau enrichment, end of plateau time and the return to baseline time of 13CO2 
excretion.
This indicates that with this breath test the determination of the time during which liver glycogen mo-
bilisation is demonstrable does not depend on the degree of 13C enrichment of the skeletal muscle 
glycogen pool.
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ABSTRACT
A diet containing naturally 13C-enriched carbohydrate combined with a 13CO2 breath test analysis 
can be used to monitor liver glycogen oxidation in persons used to a diet low in 13C, e.g., the West-
European diet. In this study, we further evaluated this test principle further by changing the way 
we label the glycogen pool. The 13C enrichment of exhaled CO2 was studied in two groups, one in 
Europe and one in Africa. The European group (n = 12) was accustomed to a diet low in 13C, and 
they went on a 13C-enriched study diet to identify liver glycogen. The African group (n = 6) was ac-
customed to a diet naturally high 13C, and they went on a diet low in 13C. The basal 13C abundance in 
exhaled CO2 was higher in the African group (1.0879 At%; atmospheric 1.1 atom percent) than in the 
European group (1.0821 At%). During the study period, the parameters for liver glycogen oxidation 
- the 13CO2 enrichment plateau, the plateau duration and the return to baseline time - did not differ 
between groups. The abundance 13CO2 in exhaled CO2 over time in the two groups was similar but 
inverse. The study confirms the use of a 13CO2 breath test to monitor liver glycogen oxidation and 
demonstrates how to use such a test in persons accustomed to s diet high in 13C.
KEY WORDS
naturally 13C-enriched carbohydrate, liver glycogen, corn, sugar cane, 13CO2 breath test
INTRODUCTION
Studies in animals and in man have shown that protracted use of 13C-enriched food increases 13C 
abundances in the body. As a result, 13C enrichment of the CO2 pool increases. When rats are fed 
with (naturally 13C enriched) maize glucose for 35 d, they expire CO2, which has the same 
13C/12C 
ratio as their dietary maize glucose.1 In humans, the 13C abundance of the CO2 pool is lower than 
the atmospheric 1.1 atom percent (At%) and changes in accordance with the dietary 13C abundance 
and the 13C abundance in the body energy stores. The 13C abundance in the energy stores reflects 
the average 13C abundance in the diet over a longer period1-3 because this lower-than-atmospheric 
abundance is found in different 13C abundance of food and food products.
The difference of the 13C abundance in different foods is determined by the isotopic fractioning of 
one of the two biochemical pathways that can be used by plants for photosynthesis. The majority 
of plants use the C3-pathway (the Calvin-Benson cycle), through which isotopic fractioning occurs. 
Carbohydrates produced through this pathway have a relative low 13C abundance of approximately 
1.082 At%. In contrast, a few other plants use the C4-pathway (the Hatch-Slack pathway) for their 
photosynthesis.4  Carbohydrates produced by C4 plants have a 13C abundance of about 1.096 At%, 
which is almost identical to that of the ambient air. The main representatives of the C4 food plants 
are corn, millet, sugar cane and pine apple.3 The difference in 13C enrichment of food products in 
the diet and even in the food-chain is caused by the different contributions of naturally 13C-enriched 
constituents, e.g., corn and cane sugar. As an example, cheese produced from corn-fed (American) 
cows has a higher 13C enrichment, 1.0989 At%, than cheese produced from grass-fed (Polish) cows, 
1.0807 At%.3
The American diet has a higher content of corn and corn-derived food than the usual West-European 
diet. Consequently, body glycogen, fat and protein stores have a higher 13C abundance. As a result, 
the exhaled 13CO2 abundance is higher in North-Americans, 1.0882 At% than in Europeans, 1.0820 
At% .3,5,6 
Corn and sugar cane are staple food in large areas of the African continent. It can readily be as-
sumed that the inhabitants of those areas will have a higher 13C abundance, though no studies have 
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been performed to confirm this assumption.
The small but consistent differences in natural 13C enrichment of carbohydrates can be used for 
metabolic studies because no further isotopic fractioning takes place further along the food-chain or 
in human metabolism.1 In subjects accustomed to a diet low in 13C (West-European), the differences 
in basal 13C abundance between the three energy pools (glycogen, fat and protein) are negligible.5 
This creates a steady basal 13CO2 abundance. When such subjects consume a diet with naturally 
13C-enriched carbohydrates for 5 d or less, only the glycogen pool shows a significant increase in 
13C enrichment.7 Because, under sedentary fasting conditions, skeletal muscle glycogen is seldom 
used, the glucose derived from liver glycogen will then be the sole source of 13C enrichment.6,8,9 
Under these circumstances, 13CO2 enrichment in breath can be used to monitor the utilization of liver 
glycogen.
In a previous study on liver glycogen kinetics we used the natural 13C enrichment of corn and sugar 
cane to label the liver glycogen pool in persons used to a diet low in 13C. The use of this 13C-labelled 
liver glycogen was subsequently followed during a period of sedentary fasting.10 
In the present study, we evaluated this test principle further by changing the way we labelled gly-
cogen. In the previous study, the glycogen pool was labelled in persons  who had a low basal 13C 
abundance; in the present study, we reversed the labelling procedure by giving carbohydrates low 
in 13C to persons accustomed to a diet high in 13C.-enriched carbohydrates. In certain areas of the 
Africa, corn, millet and sugar cane are staple foods, and, consequently, the basic 13C enrichment 
of the body energy stores is high. The African part of the study was performed in a rural village in 
Botswana. The purpose of the study was to investigate whether comparable data could be obtained 
for the parameters of liver glycogen use. If such data could be obtained, the validity of the concept 
of the test would be strengthened, and such a method could be applied in populations adapted to a 
diet high in 13C. 
PATIENTS AND METHODS
Subjects
Six healthy female volunteers (age range = 20 - 24 y) participated in the study (African group). All six 
resided at a boarding school in Mochudi, a rural village in Botswana. Their habitual diet consisted of 
corn products, sugar cane, meat and vegetables. For baking,  sunflower oil or corn oil was used. 
The control group (European group) consisted of 12 healthy volunteers living in The Netherlands. 
This group was used to a diet low in 13C. Some data from this group were published elsewhere.10 The 
characteristics of both groups are presented in Table I. 
All participants gave informed consent, and the experiment was approved by the local health authori-
ties.
The Diet
Subjects in the African group were allowed to use their habitual diet during the first day of the experi-
ment. 
For this study, a diet low in 13C-enriched carbohydrate was prepared for the African group. This diet 
was consumed during day 2. To avoid hidden sources of 13C enrichment, some food items were im-
ported from Europe. These items were beet sugar, tomato sauce and rice mix (Knorr-Nährmittel AG, 
Germany) and an artificial sweetener (Natrena, The Netherlands; see Appendix).
In the African group, no caloric restrictions were imposed during day 1 and 2. During the fasting pe-
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riod, consumption of water, coffee and tea without milk or sugar was allowed ad libitum.
The diet of the European group has been described elswhere.10 In brief, during day 1, all subjects 
consumed their habitual diet. During this day, they had a caloric intake of 80% of their calculated 
daily need (Harris-Benedict formula). During day 2, a balanced diet with a caloric intake of 120% was 
used (see Appendix). 
We used 80% of the calculated caloric intake in the study design was to obtain a sufficient depletion 
of the liver glycogen pool at the end of the day and even more after an overnight fast. The intake of 
120% during day 2 was used to ensure an ample refill with 13C-enriched glycogen during that day. 
For practical reasons, this scheme was not applied in the African group. 
During day 2, the carbohydrate part had a 13C enrichment of 1.0960 At% in the European group and 
of 1.0820 At% in the African group.
Figure 1. Overview of the 3-day experimental design for the African and for the European group.
TABLE 1.
Characteristics of African and European subjects studied.
      African   European
        group     group
         n=6         n=12
  Age (y)       21.7 (1.4)    36.3 (6.1)
  Height (cm)    161.7 (5.7)  178.6 (9.9)
  Weight (kg)      61.2 (7.2)    75.6 (10.0)
  BMI (kg/m2)      23.4 (2.1)    23.7 (2.2)
  Sex male : female         0 : 6      6 : 6
 Mean values (SD)
 BMI, body mass index
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Experimental Protocol
For both the African group and European groups, a 3-day study protocol was used (Fig. 1).
Baseline breath samples were collected during study day 1, when subjects ate their habitual diet. 
After an overnight fast, a fasting breath sample was collected. Then the group-specific diet was 
consumed during day 2. During that day, breath samples were taken at fixed intervals. The last meal 
was consumed at 6 p.m. From this time onwards all subjects fasted under sedentary conditions. The 
European group fasted for 15 h, and the African group for 24 h. Breath samples were collected at the 
times indicated in Figure 1.
The first data from the European group came in before the African group started. In order to get bet-
ter information of the last part of the curve, we then decided to extend the breath collecting period in 
the African group.
Breath Sampling
End-expiratory air samples were collected in 20-mL vacationer tubes. The rubber plug of the tube 
was removed, and a drinking straw was inserted. After a normal inhalation, the subject quietly ex-
haled through the straw. The straw was then removed and the tube was quickly closed. All breath 
samples were analysed in one laboratory.
Analytical Procedures
13CO2 enrichment in breath CO2 was measured using an Isotope Ratio Mass Spectrometer (SIRA-10, 
Series II, VG Isogas, Middlewhich, UK) fitted with an autosampler for the vacationer tubes. Breath 
CO2 was harvested by condensation in a liquid nitrogen trap. Subsequently the CO2 was released 
and led through the mass spectrometer. The measured isotope ratio was reported as percentage 
13CO2 using the PBD (Belemnitella americana) standard of 1.1235 At% as a reference.
Calculations and statistics
During day 1, the 13CO2 enrichment in breath was measured serially to observe any influence of the 
habitual diet consumed during the day.
For each subject, the baseline 13CO2 abundance was calculated as the mean of the two fasting ob-
servations at the start of day 2. The individual change in 13CO2 enrichment measured during day 2 
and 3 was expressed in atom percent excess (APE) above this baseline.
In the analysis, the body CO2 pool was considered to be one compartment. The 
13C-enrichment of the 
CO2 pool at any given time is the result of the simultaneous processes of elimination and production. 
The elimination of 13CO2 follows the half-life time of the CO2 pool. When the half-life time is 60 min-
utes the first-order rate constant related to the half-life of the process (k) is 0.0115 (time in minutes-
1).11  With this constant, an elimination curve can be constructed by application of the equation 
APEt2 = APEt1x e
-0.0115 x (t2-t1)
Assuming that carbohydrate absorption from the gut is completed 4 h after the last meal, then the 
application of this equation to the 4-h postprandial data ( t1) predicts a theoretical elimination curve 
for 13CO2 present at that time. We subtracted the so calculated elimination curve from the actually 
measured data. The resultant curve reflects the 13CO2 produced after t1 and entering the CO2 pool. 
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As stated before, the liver glycogen pool will be the only pool supplying 13C-enriched substrate un-
der sedentary conditions. Hence, the resultant will reflect the contribution of labelled liver glycogen 
toward oxidation.
During the night, a plateau phase in 13CO2 enrichment can be observed. The 
13C enrichment at pla-
teau level, the duration of the plateau and the subsequent time interval to return to baseline 13CO2 
enrichment were measured. The duration of the plateau was calculated as the postprandial time at 
which, after the plateau was reached, the 13CO2 enrichment started to decline for more than 10%.
Studentʼs t test was used for paired and unpaired data. P  ≤ 0.05 was considered significant.
Figure 2. 13CO2 enrichment (mean and SD) in exhaled breath in the European group and the Afri-
can group during the 3 days of the experiment. M is the time when a meal was consumed.
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RESULTS
The results of the 13C-enrichment analysis of the breath CO2 are presented in Figure 2.
In the African group, the 13C enrichment showed a considerable variation during day 1. The mean 
13CO2 enrichment was 1.0899 At% (SD = 0.0008) after breakfast, 1.0879 At% (SD =  0.0008) before 
lunch, 1.0901 At% (SD = 0.0008) directly after dinner and 1.0911 At% (SD =  0.0005) 3 hours after 
dinner.
The breath samples from before lunch had a significantly lower 13CO2 enrichment than those of the 
other three measuring points. All values were significantly higher than the day one values of the 
European group (mean = 1.0820 At%, SD = 0.0006, P < 0.001). No significant variation in the 13CO2 
enrichment was observed in the European group during day 1, while they used their habitual diet.
During day 2, the mean basal (fasting) 13CO2 enrichment was 1.0879 At% (SD = 0.0009) in the 
African group and 1.0821 At% (SD = 0.0004) in the European group (P < 0.001).
In the African group, 13CO2 enrichment declined briskly when the diet low in 
13C was started. The low-
est abundance was reached 2 hours after the last meal, at a mean 13CO2 enrichment of 1.0824 At% 
(SD = 0.0002). This value was not significantly different form the baseline 13CO2 abundance in the 
European group, as was expected.
During the sedentary fasting period, a gradual increase in 13CO2 enrichment was observed in the 
African group. The increase lasted until after about 18 hours of fasting, and 13CO2 enrichment levelled 
out at 1.0854 At% (SD = 0.0003), which was different from the basal 13CO2 enrichment of 1.0879 At% 
(P = 0.003).
The 13CO2 enrichment pattern in the African group followed the inverse pattern of the control group. 
The inverse relationship became even more evident when the 1.0854 At% enrichment level was 
taken as baseline for the African group. (Fig 3)
Using the baseline of 1.0854 At% for the African group the end of plateau time was 11.7 h (SD = 0.82) 
in the African group and 13.5 h (SD = 1.17) in the European group (NS). The return to baseline time 
was 18.0 h (SD = 1.79) in the African group and 19.0 h (SD = 1.79) in the European group (NS).
Figure 3. 13C-enrichment in breath CO2 in atom percent excess (APE) starting at the time of the 
last meal. The basal enrichment was the 8 am fasting value at day 2 for the European  group and 
the 18 and 20 hours after the last meal value for the African group. (see discussion). 
∆ are the actual data,   is the CO2 wash-out curve and    is the subtraction of the wash-out curve 
and the actual data. 
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DISCUSSION
The 13C enrichment of breath CO2 depends on the 
13C enrichment of the substrates used for CO2 
production. The purpose of the present study was to validate the 13CO2 breath test as an index of liver 
glycogen oxidation. Validation was done by comparing the effect of giving 13C-enriched carbohydrate 
to non-13C-enriched persons and non-13C-enriched carbohydrate to 13C-enriched persons. 
The non-13C-enriched persons group consisted of a group of Europeans accustomed to a diet low in 
13C, and the group of 13C-enriched persons consisted of Africans accustomed to a 13C-enriched diet. 
An inverse pattern of data was expected between the two groups.
In the literature, no data were available on the CO2 
13C-abundance in persons living in Africa.
In view of the data from North-America and Europe, 13CO2 abundance in African inhabitants used to 
a staple food of corn and sugar cane was expected to near the North-American level.
Our study confirms this assumption. In the African group, the mean CO2 
13C enrichment was 1.0879 
At% (SD = 0.0009) after an overnight fast. Data of basal 13CO2 abundance in different cities in the 
USA showed a mean of 1.0882 At%, which is in the same range as the African data.3 In the African 
group, when compared with the basal 13C-enrichment after an overnight fast (0800-h value at day 2), 
the 13C enrichment of breath CO2 was higher after breakfast (1.0899 At%, SD = 0.0008, P = 0.01) and 
after dinner (1.0913 At%, SD = 0.0005, P < 0.001). The CO2 
13C enrichment measured just before 
lunch did not differ from baseline value, which suggests a direct influence of the 13C-enriched food 
on breath 13CO2 enrichment. Part of the absorbed food will be directly oxidized. This direct oxidation 
will cause a rise in 13C enrichment of the CO2 pool if the 
13C enrichment of the oxidized food is higher 
than the basal 13C enrichment.
In contrast to the African group, the 13CO2 enrichment in European group did not show any dietary 
influence during the first day of the experiment (Fig. 2).
In the African group, 13CO2 enrichment decreased to basal European level during day 2, when the 
diet low in 13C (as in West-European) was consumed.
In the European group, the opposite pattern was observed during consumption of the diet higher in 
13C. However the maximum values in this group did not completely reach the African basal value of 
13C abundance in breath CO2. 
This result may be explained by the differences in 13C enrichment of the body protein and fat pools 
between the two study groups. Animal studies showed that the consumption of 13C-enriched carbohy-
drate over a prolonged period increases the 13C-enrichment of the protein and fat pools1. Therefore, 
13C enrichment of the body protein and fat pools in the African group should be higher than that in 
the European group. Thus, the higher 13C values in the Africans can be explained by the oxidation of 
13C-enriched protein and fat.
A remarkable observation was that the 13CO2 enrichment in the African group did not return to the 
original enrichment level measured after an overnight fast (1.0879 At%) but levelled out to approxi-
mately 1.0854 At% after 18 h of fasting. A likely explanation for this phenomenon is that the actual 
mean 13C-enrichment of the fat and protein energy stores are 1.0854 At%. After about 18 hours of 
fasting, the contribution of liver glycogen to oxidation has declined, and muscle glycogen is hardly 
used during a sedentary fast. Therefore, at this time in the fasting state, the 13CO2 enrichment of 
1.0854 At% reflects the mean 13C-enrichment of fat and protein as the sources of CO2 production.
6,8-
10 
Taking this value of 1.0854 At% as baseline value, we compared the enrichment profiles over time 
during the study of the two groups. The curves show a striking similarity, almost a mirror image of 
one another. The 13CO2 wash-out formula was applied to the actual, measured 
13CO2 enrichment 
measured at 4 hours postprandial. Thus, the constructed curve was subtracted from the measured 
one. In the African group, the inverse of the plateau of the European group was observed. The return-
to-baseline time was identical in both groups (Fig. 3).
This outcome confirms the idea that the liver glycogen is used for oxidation at a steady rate during 
Dietary 13C and 13CO2 breath test for liver glycogen
boek_19-03-'03 19-03-2003, 15:5369
70 71
the plateau phase and gradually declines after about 14 hours of sedentary fasting. After about 20 
hours of fasting, the contribution of previously labelled liver glycogen is reduced to such a level that 
it cannot be measured anymore with this technique.10 
In the control group, no data were collected beyond 15 hours of fasting. However, preliminary results 
of a later study in which data were collected during a 24 hours sedentary fast (unpublished observa-
tions) show a pattern of return-to-baseline beyond 15 hours of fasting, similar to the one observed in 
the African group.
The caloric intake in the European group was 80% of their habitual intake on day 1 and 120% on 
day 2 of the study.  We assumed that this change will result in a higher 13C-enrichment level of the 
liver glycogen and we expected a greater change in 13C-labelling in the European group than in the 
African group. This change should produce a higher peak value in the Europeans, but the duration of 
the plateau phase and the return to baseline time were not altered.
It could be speculated that the area under the curve represents the amount of labelled glycogen used 
for oxidation. However, for such an estimation, other parameters such as CO2 production and the 
size of the CO2-pool are needed. Those data were not available in this experiment.
The observed smaller standard deviation of the data at all points in time in the African group can be 
explained by the fact that the African group lived at a boarding school. As a result all six had used the 
same diet for a long time. The European volunteers lived individually and had a much more diverse 
dietary pattern.
This study shows that the 13C abundance of the breath CO2 in Africans accustomed to a staple diet 
of corn and sugar cane is significantly higher than in Europeans used to a staple diet low in 13C. 
Moreover, it confirms our hypothesis that studying liver glycogen kinetics with a naturally 13C-
enriched carbohydrate label in a low-13C-enriched individual produces similar results as using a low-
13C-enriched carbohydrate label in a high-13C-enriched individual. This corroborates the use of a 
13CO2 breath test as a tool to monitor liver glycogen oxidation. It also opens possibilities to carry out 
studies in persons used to a 13C-enriched diet.
This study substantiates again that knowledge about the 13C enrichment of the habitual diet is es-
sential in metabolic studies using naturally 13C-enriched labels.
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APPENDIX
Diet instructions African Group, low 13C-enriched diet for day 2
Breakfast
 bread
 peanut butter
 coffee or tea with “Dutch” beet sugar
 margarine
 coco-bread
Between Breakfast and Lunch
 coffee or tea with beet sugar
 and / or cola light
 and / or an apple or an orange
Lunch
 macaroni or potatoes
 beans
 “Dutch” tomato sauce
 tomatoes
 salad made of salad, paprika, apple and oranges
 sunflower oil
Between Lunch and Dinner
 coffee or tea with beet sugar
 and / or cola light
 and / or an apple or an orange
Dinner
 rice
 peas
 cabbage with onions baked in sunflower oil
 “Dutch” rice mix
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 desert of apple and orange
 coffee or tea with beet sugar
 Do not use milk, except for tea and coffee. Do not use any other animal products, no  
 meat, no maize and maize-products, no sugar (except for the sned “Dutch” beet sugar),  
 no cookies, no pineapple.
 Salt, pepper, curry and paprika are allowed.
 During the fasting period coffee and tea with the Natrena artificial sweetener or cola light  
 are allowed.
Diet instructions for the European Group, 13C-enriched diet during day 
2 (Example of 2800 kcal [11700 kJoules] diet)
Breakfast of Porridge Consisting of 
 150 g 50% skimmed milk
 120 g fresh cream 
 150 g water 
   30 g custard powder (derived from maize-flour)
   38 g cane sugar
Between Breakfast and Lunch
 300 g 50% skimmed milk
   30 g cornflakes
  7.5 g cane sugar
Lunch of Porridge Consisting of
 150 g 50% skimmed milk
 120 g fresh cream
 150 g water
   30 g custard powder (derived from maize-flour)
   38 g cane sugar
Between Lunch and Dinner
 300 g 50% skimmed milk
   30 g cornflakes
  7.5 g cane sugar
Dinner
 150 g minced meat (beef) fried in 25 g butter
 100 g sweet pepper
   70 g maize for maize polenta
   20 g sauce powder
  Unlimited use of tea or coffee without sugar and milk and non-caloric drinks is al 
  lowed.
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4.4
The 13CO2 breath test to monitor liver glycogen oxidation in 
man. A study of its reproducibility.
A. A. Tanis, T. Rietveld, J. L. D. Wattimena, J. W. O. van den Berg
and G. R. Swart.
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Abstract
Background: Recently we described a 13CO2 breath test to monitor liver glycogen oxidation over 
time. The present study evaluated the reproducibility of this breath test. 
Methods: In six healthy volunteers, liver glycogen was labelled with naturally 13C-enriched carbo-
hydrate. Subsequently the oxidation of this labelled liver glycogen was studied by measuring the 
changes in 13C-enrichment of breath CO2 during a period of 24 hours fasting. The procedure was 
repeated after an interval of six weeks.
Results: The mean baseline 13CO2 abundance did not differ, neither between the two experiments, 
1.08215 (sd 0.00014) At% vs. 1.08201 (sd 0.00020) At% (n.s.); mean difference  0,00014 At%, sddiff 
of 0,00038 At%, nor did it differ from expected values in the Dutch population (1,0820 At%), n.s. The 
breath 13CO2 -enrichment showed a steady state excretion (plateau phase) at 2.62 x 10
-3 (sd 0.48 x 
10-3) atom percent excess (APE) in the first series and at 2.53 x 10-3 (sd 0.75 x 10-3) APE in the sec-
ond series (n.s.). The end of the plateau phase was 13.2 (sd 1.5) h postprandial in the first and 13.3 
(sd 1.5) h in the second experiment (n.s.); 
Comparison of both series according to Bland and Altman showed a mean difference of   0.0 h, (sddiff 
2.1).  Breath 13CO2 enrichment returned to baseline values at 23.1 vs. 23.2 h postprandial (n.s.) with 
a mean difference of –0.2 h, (sddiff 2.8). 
Conclusion: The 13CO2-breath test to study changes in liver glycogen oxidation in the postprandial 
period shows reproducible results at the group level, when mean values for selected criteria are 
taken as endpoints. However, the large standard deviations suggest that measuring at more time 
points would improve the results. This would also increase the potential for reliable clinical interpreta-
tion in testing individual cases.
 Key words
13C-carbohydrate
13CO2 breath test
glycogen 
natural 13C-enrichment
liver
Introduction and Background
Recently we described a breath test that was designed to monitor the oxidation of liver glycogen 
over time.[1-3]  In this test liver glycogen is labelled with naturally 13C-enriched carbohydrate.[ 4-6 ] 
There is a continuous process of glycogen synthesis and degradation, mainly in fed state conditions, 
the net result being positive in the fed state and negative while fasting. Part of the glucose moieties 
released from glycogen degradation will be oxidised, part will be recycled to glycogen or enter other 
metabolic routes. When liver glycogen is labelled with 13C-enriched glucose, the mobilisation and oxi-
dation of this 13C-labeled glucose results in an increase in 13C-enrichment of the body CO2 pool. This 
increase will be reflected in an increase in the 13C-enrichment of breath CO2. Monitoring this increase 
in breath 13CO2 over time to thereby gauge glycogen oxidation is the concept of the 
13CO2  breath 
test.  Changes in 13CO2 excretion are representative only of changes in that part of liver glycogen that 
is broken down and oxidised; they do not represent net glycogen breakdown. Glycogen is stored in 
both liver and skeletal muscle. Thus, muscle glycogen metabolism could interfere with the measure-
ment of liver glycogen mobilisation. However, under sedentary conditions muscle glycogen is hardly 
utilised, and thus interference should then be negligible [3,6]. Consequently, when the breath test is 
reproducibility of 13CO2 breath test for liver glycogen
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performed in the sedentary fasting state, the changes in 13C-enrichment of breath CO2 can be directly 
linked to the oxidation of 13C-labelled liver glycogen. 
A glycogen oxidation breath test could be used to study net liver glycogen breakdown for energy pro-
duction in patho-physiological studies in patients with a deranged glycogen metabolism like diabetes 
mellitus and liver disease. To be applicable, the breath test should provide reproducible results. This 
was tested in the present study in a group of six healthy volunteers who performed the breath test 
twice with an interval of six weeks in between. 
Methods
Diets
The habitual diet of all participants was a typical West-European diet, which contains a low 13C-abun-
dance [7,8]. All subjects followed a three-day study protocol as shown in figure 1. The details of this 
protocol have been described previously [1-3]. In short, all participants used their habitual diet (80% 
of calculated caloric requirements; Harris-Benedict, light activities) during day one. This hypo-caloric 
intake was chosen to obtain a relative depletion of the liver glycogen stores. The basal 13C-abun-
dance in breath CO2 was determined during this day. On the second day a standardised labelling diet 
containing naturally 13C-enriched carbohydrate (120% of the individually calculated caloric require-
ments; Harris-Benedict, light activities) was consumed. In actual practice, three semi-solid meals 
(custard pudding, polenta) were used, and some semi-solid “snacks” (corn flakes and milk). This 
was followed by a period of 24-hours fasting under sedentary circumstances. The composition of the 
13C-enriched diet has been described before [1,2].
Measurements
At defined intervals breath samples were collected (figure 1). The CO2 production was measured by 
indirect calorimetry (Deltatrac®, Datex, Finland) at 8 AM, at noon and at 4 PM during day three, i.e. 
after 14, 18 and 24 hours of fasting. The study was repeated after an interval of six weeks. Between 
the two studies the subjects had no dietary restrictions. The technique of breath sampling has 
been described before [1,2]. For the 13C-enrichment measurements the ABCA Isotope Ratio Mass 
Spectrometer (Europa Scientific, Crewe, Cheshire, UK) was used. The calibration was carried out 
with a certified standard reference gas (GS-17).
Calculations
The calculations used to interpret the data have been described before [1,2]. In short, in these cal-
culations it is assumed that four hours after the last meal, intestinal glucose absorption and direct 
oxidation will have been completed. This assumption was based on the study of 13CO2 gastric emp-
tying breath tests where it was found that the half-time for gastric emptying of semi-solid diets was 
23 min  indicating that gastric emptying must be practically completed at 2 h. (5 x T/2) postprandial 
[9] . In practice, four hours is taken as a safe limit point for direct absorption of glucose.  A wash-out 
curve is then calculated, representing the excretion of 13C-labelled CO2 already present in the body 
at that point in time (i.e. 4 h postprandial), and supposedly representing oxidation of labelled glucose 
directly after absorption. Then, any later increase in 13C-labelled CO2 must arise from oxidation of tis-
sue (i.e. glycogen) derived glucose. This process can be calculated by subtracting the computed 
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Fig. 1  The study design
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washout curve from the actually measured 13CO2 excretion.  The resulting curve typically shows a 
plateau in 13CO2 excretion, to be followed by a gradual linear decline to baseline levels of excretion. 
Two characteristics of this curve have been studied, the end of plateau time (EOPT) and the return 
to baseline time (RTBT). [1-3].
The beginning of the plateau phase was defined by the average 13CO2 enrichment measured at 6, 
8 and 10 hours postprandial. The end of the plateau phase (EOPT) was defined as the point in time 
where a decline of more than 10% in 13CO2 enrichment was observed. In fact, a moving plateau was 
calculated using three sequential data points. When the next (fourth) point showed a value more than 
10% lower than the preceding plateau, the last point of the three sequential points was designated 
as the end of plateau. The data following the end of the plateau phase were analysed with linear 
regression analysis. The time at which the regression line reached the initial baseline value was 
defined as RTBT. 
The study protocol was approved by the hospital medical ethics committee. 
Statistical analysis
The mean results, the standard deviations, the mean differences between groups and the standard 
deviations of the mean differences were computed. The paired T-test and the Bland-Altman analysis 
for repeated measurements [10] were performed to compare the two experiments.   For the T-test 
a p-value of ≤ 0.05 was considered to be significant. In the Bland-Altman analysis the 95% range of 
agreement for individuals was calculated by multiplying the standard deviation of the difference by 
1.96. This range of agreement was then viewed in relation to the mean value and the mean differ-
ence of the mean. Based on this information, a decision on acceptability was made. 
Results
Six healthy volunteers, 1 female and 5 male, participated in the study. The mean age was 23.5 (SD 
1.5) year, the mean height 1.79 (SD 0.10) meter, the mean weight 69.7 (SD10.0) kg and the mean 
body mass index was 21.7 (SD1.5) kg·m-2.
The results of the repeated breath tests in all 6 individuals are stated in table 1. A detailed example 
of the measured and calculated data of a single breath test in one individual is shown in fig. 2. An 
overview of all repeated 13CO2 excretion curves in the 6 subjects is depicted in figure 3.
The mean basal 13CO2 abundance during day one was not different in the first and the second 
experiment, 1.8257 and 1.0821 At% (n.s.). This level of enrichment is not different from previously 
measured values (1.0820 At%; n.s.) in the Dutch population.  At day two after the consumption of 
the 13C-enriched diet the mean maximum rise in 13C-enrichment in breath CO2 was 5.7x10
-3 APE (SD 
0.3x10-3) for the first and 5.4x10-3 APE (SD 0.9x10-3) for the repeated experiment (n.s). The mean 
13C-enrichment at plateau phase was 2.62 x 10-3 APE (SD 0.48 x 10-3) and 2.53 x 10-3 APE (SD 0.75 
x 10-3) respectively. Taking the 4 h postprandial cut-off point, the end of plateau time was observed 
at 13.2 (SD 1.5) h. and 13.3 (SD 1.5) h. postprandial in the repeated studies (n.s.). The return to 
baseline time was 23.1 (SD 2.4) h. postprandial and 23.2 (SD 1.7) h respectively.
The Bland-Altman analysis was performed showing mean differences of 0 and –0.2 hours for EOPT 
and RTBT times respectively (fig 4). The CO2 production at 14, 18 and 22 h postprandial in the first 
series was 192 (SD 33.8) ml/min at 14 h, 187 (SD 24.3) ml/min at 18 h and 193 (SD 19.8) ml/min at 
22 h. In the second series these values were 187 (SD 20.7) ml/min, 186 (SD 22.0) ml/min and 188 
(SD 19.7) ml/min respectively.  These differences are not significant; Individual results of CO2 produc-
tion measurements can be read from table 3. 
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Table 1. The repeated breath tests in six individuals, showing the individual and the mean results 
on the four main features of the test: the baseline 13CO2 abundance in atom percent, the 
13CO2 en-
richment at plateau level in atom percent excess (APE), the end of the plateau time (EOPT) and 
the return to baseline time (RTBT) in hours postprandial.  The mean difference and the standard 
deviation of the difference are given.
Figure 2.
An example of the results of the breath test in one of the individuals. The bold line with the dia-
monds indicates the measured values. The dotted line indicates the calculated elimination curve 
of the 13CO2 produced starting at four hours postprandial. The line with the triangles results from 
subtraction of the 13CO2 elimination curve from the measured 
13CO2 data curve. The horizontal 
line is plotted at the plateau level. “EOP” indicates the end of plateau time (EOPT). The point 
where the regression line crosses the X-axis is the return to baseline time (RTBT).
�������������� ����� �� �������
�� � ������������ ���
� � �� �� �� �� ��
�����
�����
�����
�����
�����
�����
�����
�
��
��
��
��
��
��
��
�
�
�
��
���
����
�������� ���� ���
���������� �������� ���
������ �� � ��
�������
���������� ����
Baseline 13CO2 13CO2 at plateau End of plateau 
time
Return to baseline 
time
in At% in APE in h postprandial in h postprandial 
Exp     1st              2nd     1st             2nd     1st              2nd     1st              2nd 
Subj.1 1.08214   1.08182 0.00255    0.00287     13               13    25.6          25.2
Subj.2 1.08218   1.08221 0.00290    0.00313     12               12    22.1          24.4
Subj.3 1.08218   1.08173 0.00178    0.00260     12               10    19.2          23.2
Subj.4 1.08221   1.08229 0.00242    0.00120     13               12    22.8          20.5
Subj.5 1.08162   1.08208 0.00295    0.00220     15               14    25.3          22.2
Subj.6 1.08257   1.08201 0.00309    0.00319     10               14    23.6          23.8
Mean
SD
1.08214   1.08182
0.00030 0.0002
0.00255    0.00287
0.00048    0.00075
    12.5            12.5
      1.6            1.5
    2.32           3.2
    2.4             1.7
Mean diff
SD diff
             0.00014
             0.00038
              0.00008
              0.00075
                          0
                       2.1  
                     -0.1
                      2.7
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Figure 3.
The 13C-data of the two experiments are combined to show the differences in a graphic way ( vol 
A , B). The dotted lines show the measured data, the  diamonds show the calculated elimination 
and the triangles show the resultant after the calculated elimination data were subtracted from 
the measured data.
The x-axis represents hrs postprandial. The y-axis represents 13CO2  as APE in breath.
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Figure  4.
Two series of glycogen breath tests compared with the Bland-Altman technique. Results of the 
end of plateau time (EOPT) and Return to baseline time (RTBT) are plotted. 
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Table 2
CO2 production – comparison of two series
 Time postprandial   14 hr  18hr  22hr 
 experiment     1 st 2nd   1st 2nd   1st 2nd
 Mean VCO2 ml/min  191.7 199.2 187.0 185.7 193.2 197.7
 SD      33.8   24.3   20.7   22.0   19.8   19.7
 Mean diff in ml/min        2.5       1.3      5.5
 SD diff       15.0       7.0    14.0
reproducibility of 13CO2 breath test for liver glycogen
82 83
Discussion
Recently we described a 13CO2 breath test to monitor the oxidation of liver glycogen in the fasting 
state [1-3]. This test measures net 13C-labelled glycogen consumption for energy production. It is well 
known that in the fed state there is extensive recycling of glucose moieties, with up to 50 % of just 
liberated glucose being used anew for glycogen synthesis. In the fasting state, recycling continues, 
be it at a low level [11]. It may thus be presumed that this cycling process will not appreciably reduce 
the value of a 13CO2-breath test that is performed in fasting state conditions. Since glucose, liberated 
from glycogen, can either be oxidised, used in other metabolic processes, or be recycled to glycogen 
again, a breath test measures only net glycogen use (i.e. oxidation). Because it is unlikely that 13C-
glucose originating from 13C-glycogen breakdown will be selectively used for processes other than 
oxidation, and since cycling is low during fasting, the end of 13CO2 excretion in the breath test may be 
taken as the end of previously deposited 13C-labelled glycogen.  In this breath test the liver glycogen 
is labelled with naturally 13C-enriched carbohydrate. During subsequent fasting the excretion of 13C-
enriched CO2 in breath almost exclusively reflects the oxidation of labelled glycogen derived glucose. 
It has been demonstrated that the contribution from other potentially labelled sources like protein and 
fat can be ignored, even after three days of labelling [3]. When this test is performed under sedentary 
conditions, when there is hardly any mobilisation of muscle glycogen [3], it is actually liver glycogen 
oxidation that is being monitored. Thus, the performance of a 13CO2-breath test is relevant to study 
when one is interested in liver glycogen stores. The present study was performed to evaluate the 
reproducibility of this breath test. 
Six healthy volunteers followed the same protocol twice with a period of six weeks in between. Since 
no dietary restrictions were imposed on the subjects either before the first test or in the interval 
between the two tests, the basal 13C-enrichment of the breath CO2 measured during the two experi-
ments reflects the basal 13C-enrichment of the habitual diet. The observed 13C-enrichment compared 
well with the known values of the West-European society [8]. This relative low basal 13C-enrichment 
is a prerequisite for this breath test in which the increase in 13C-enrichment through labelling with 
naturally enriched material is rather low [7]. In our repeated test, there was no effect noticeable on 
basal 13C-enrichment as a result of the labelling during our first study. It is unlikely that during our 
studies 13C-labelled material, after incorporation in fat or protein and subsequent oxidation of that 
new product, will have contributed to 13CO2 formation and thus contaminated our results. A higher 
basal 13C-enrichment of the breath CO2 would then have been observed. 
Comparing the results of the two experiments there were no significant differences in end of plateau 
time or return to baseline time when the paired t-test was applied. This indicates that the test will 
give reproducible results when groups of individuals are studied. Plateau values, according to the 
protocol, were calculated on three measured values for 13CO2 excretion; standard deviations of the 
mean value were rather large. Consequently, any errors in these measurements will have a relatively 
large impact on the resulting plateau level. In future studies, more frequent breath sampling should 
be considered to improve the data. 
For clinical purposes the end of the plateau phase and the return to baseline time are of special inter-
est. The first indicates a decline in the availability of (labelled) liver glycogen for oxidation. Assuming 
ongoing and equal energy expenditure, this suggests recruitment at that point in time of other meta-
bolic routes for energy production, like an increase in the rates of gluconeogenesis and lipolysis. The 
latter indicates the time when the contribution of (labelled) glycogen reaches such a low level that it 
cannot be measured anymore, suggesting the end of the availability of labelled glycogen for oxida-
tion. Frequent sampling especially around those two points in time could delineate those points in 
time with even more precision. 
The Bland - Altman analysis showed quite a wide range in the standard deviation of the difference. 
However the mean differences of repeated measurements for End of Plateau time and Return to 
Baseline time were almost zero.  
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Conclusions
We conclude that the naturally 13C-labelled breath test is a reproducible tool for studying groups of 
individuals. However, more frequent measurements are indicated to get a better definition of the end 
of plateau and return to baseline times. This might improve the test variation to a level where is will 
be applicable in individual cases. 
The 13CO2 breath test is an interesting and promising tool to study the oxidation of the liver glycogen 
during fasting as a (patho-)physiological or clinical test in patients suspected of having a deranged 
liver glycogen storage capacity. 
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The 13CO2 breath test for liver glycogen oxidation after a 
three-day labelling of the liver with a 
naturally 13C-enriched diet.
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Abstract
OBJECTIVE: When naturally 13C-enriched carbohydrate is used to label hepatic glycogen, 13C-liver 
glycogen oxidation can be monitored subsequently by measuring the 13C-enrichment of breath CO2 
during a sedentary fast. In our previous breath test studies, we used a 1-d labelling protocol to enrich 
liver glycogen. Others found that after 3-d of labelling the liver glycogen 13C enrichment is identical to 
the dietary carbohydrate 13C enrichment. 
METHODS: We compared a diet protocol in which naturally 13C-enriched carbohydrate was given for 
3 d before the breath test with our previously applied 1-d labelling design. The 13CO2 breath test was 
combined with indirect calorimetry. The results were compared with those from our previous studies. 
In addition, we compared liver glycogen oxidation rates with those from our present technique and 
different techniques as used in other published studies.
RESULTS: Six healthy volunteers were included in this study. The 13C enrichment of breath CO2 at 
the plateau level excretion level did not differ after 1 or 3 d on a labelling diet. However, the end of 
plateau time tended to be later after the 3-d diet, 14.3 h versus 12.5 to 13.5 h postprandially in the 
1-d labelling studies. Also, the return to baseline time was later in the 3-d study, at 25.8 h versus 19.0 
to 23.2 h postprandially after 1 d of labelling. The liver glycogen oxidation rate was similar in both 
techniques until 17h postprandially. After this time the 3-d labelling protocol showed a higher level of 
liver glycogen oxidation.
CONCLUSION: The results indicated that the labelling of liver glycogen is slightly less complete 
after 1 d on a 13C-enriched diet as compared with 3-d labelling. Our 13C breath test results compared 
rather well with studies from the literature using the 13C-NMR technique, the D2O technique, or the 
13CO2 breath method to measure liver glycogen oxidation.
KEY WORDS:
 13CO2, breath test, naturally 
13C-enriched diet, glycogen oxidation, glycogenolysis, liver
INTRODUCTION
We previously described a non-invasive way to monitor liver glycogen oxidation.1-4
In this method the body glycogen stores are labelled with a diet that contains 13C-enriched carbohy-
drate. When the labelled glycogen is oxidized, 13CO2 is produced and the 
13C-enrichment of the CO2 
pool will increase. This increase can be measured in breath CO2. 
During a sedentary fast muscle glycogen is barely used.3,5 Thus, under those conditions, the increase 
in 13C-enrichment of the CO2 is caused by the oxidation of liver glycogen.  Therefore the 
13C-enrich-
ment of breath CO2 can be used as a parameter for liver glycogen oxidation during a sedentary 
fast.
In our previous experiments, the period during which glycogen is labelled with naturally 13C-enriched 
carbohydrate was 1 d. On the day before the 13C-labelling, subjects used a hypo-caloric diet (80% 
of Harris-Benedict calculated energy requirements). We assumed that such a diet, followed by an 
overnight fast, would adequately deplete the liver glycogen stores. During the day of labelling, a hy-
per-caloric diet (120% of Harris-Benedict calculated energy requirements) was consumed to ensure 
an ample supply of carbohydrate to refill the glycogen stores.
Gay et al. demonstrated that on a 13C-enriched carbohydrate diet the 13C-enrichment of liver glyco-
gen is identical to the dietary 13C-enrichment after 3 d.6 
In contrast to our study design, they did not attempt to deplete the liver glycogen pool before they 
started the 13C-diet. Their experience implicated that the labelling period of 1 d, which we used in 
our experiments, was to brief. Consequently, we could have calculated erroneously low rates of liver 
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glycogen oxidation. 
The present study addresses this issue. The breath test was carried out after 3 d of labelling the gly-
cogen pool. During these 3 d, an iso-caloric (100% Harris-Benedict calculated energy requirements), 
naturally 13C-enriched carbohydrate diet was consumed. The results were compared with those ob-
tained in our previous studies, which were based on a one-day labelling period.
MATERIALS AND METHODS
Subjects
Six healthy volunteers, two male and four female, participated in the study. Their mean (± standard 
deviation) age was 24.2 (1.7) year, the mean height was 176.7 (10.5) cm, the mean weight 65.2 
(12.1) kg, and the mean body mass index was 20.8 (2.5) kg/m2. All participants were all in good 
physical condition and they did not take any medication. They habitually consumed a low 13C-abun-
dance (European) diet. Before the study there were no diet restrictions. All gave informed consent. 
The local ethics committee approved the protocol. 
Subjects in control studies
Data from three of our previous studies were compared with the present breath test results. Study 2,4 
(Table I) was performed in 12 healthy subjects, six male and six female, with a mean age of 36.3 (6.1) 
y, mean height of 178 (9.9) cm, mean weight of 75.6 (10.0) kg, and an mean body weight of 23.7 (2.2) 
kg/m2. Twelve healthy individuals, six male and six female, were included in study 3,2  with a mean 
age of 36.3 (6.1) y, mean height of 178 (9.9) cm, mean weight of 75.6 (10.0) kg, and an mean body 
weight of 23.7 (2.2) kg/m2. In study 4,3 six healthy subjects, five male and one female, participated, 
with a mean age of 23.9 (1.4) y, mean height of 178.7 (10.5) cm, mean weight of 69.7 (10.0) kg, and 
a mean body mass index of 21.8 (1.5) kg/m2. As a control group for the glycogen oxidation rates, 
subjects from study 2,4 were used.
Study protocol
The study protocol is shown in Figure 1. Background and details about the study diet have been de-
scribed previously.1,2 The study was carried out over a period of 4 d. The night before the start of the 
13C-enriched diet, the subjects fasted from midnight onward. Basal 13CO2-enriched breath samples 
were taken at the start of day 1. The 13C-enriched diet was consumed between 8 a.m. and 6 p.m. on 
day 1, 2 and 3. 
Indirect calorimetry
Energy expenditure was measured by indirect calorimetric measurements (Deltatrac®, Datex, 
Finland) every morning before breakfast and 3-hourly during the 24 hour sedentary fasting period, 
which started at day 3 at 6 p.m.
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Fig. 1. Outline of the study protocol
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The naturally 13C-enriched carbohydrate diet
Caloric intake was calculated (Harris-Benedict, light activities) and all subjects consumed the pre-
scribed amount during all study days. Calorie-free drinks were allowed ad libitum. 
The study-diet consisted of 60% (wt/wt) carbohydrate, 27% fat and 13% protein. Eighty percent of 
the carbohydrate was naturally 13C-enriched and came from corn and sugar cane. The overall calcu-
lated 13C-enrichment of the carbohydrate in the diet was 1.093 atom percent (at%; the usual Western 
European diet has a 13C-enrichment of 1,082 at%).7,8 
Breath sampling
Alveolar air samples were collected in duplicate in 20-mL Vacutainer tubes (Becton Dickinson 
Vacutainer Systems Europe, Plymouth, UK). After the rubber plug was removed a drinking straw 
was inserted. After a normal inhalation, the subject quietly exhaled through the straw. The straw was 
removed and the tube closed.
Isotope analysis
An Isotope Ratio Mass Spectrometer (ABCA, Europe Scientific, Crewe, Cheshire, UK) fitted with an 
autosampler was used to measure the 13C-enrichment in breath CO2 samples. The measured isotope 
ratio was reported as atom percent 13C in CO2. 
A certified reference gas standard (GS-17) was used for calibration. 
The 13CO2 enrichment after an overnight fast on days 1, 2, 3, and 4 were expressed in atom percent. 
All other data were expressed in atom percent excess of 13C above baseline.
Calculations
The baseline 13C abundance in breath CO2 was defined as the 
13CO2 abundance on day 1 before 
breakfast. Combining the half-life time of the CO2 pool (60 minutes)
9 with the assumption that the 
absorption of carbohydrate from the gut is completed four hours after the last meal, the contribution 
of liver 13C-glycogen toward 13C-enrichment of breath CO2 could be calculated as described previ-
ously.1,2
The 13CO2 enrichment at plateau level, the duration of the plateau phase, the subsequent decline in 
13CO2 and the moment when enrichment decreased to baseline 
13CO2 value were used to describe 
the various phases of liver glycogen catabolism.
Glycogenolysis was calculated from the 13C-enrichment of breath CO2 and the respiratory gas ex-
changes. Three considerations were made. The first consideration was that, in 3 d, the diet would 
not affect the 13C-enrichment of the body lipids and proteins; this was demonstrated by Gay et al.6 
The second one was that muscle glycogen would not significantly contribute to the carbohydrate 
oxidation during a short sedentary fast.  This was found in one of our previous studies in which we 
created a higher level of 13C enrichment of muscle glycogen; this higher enrichment did not alter the 
outcome of the test.3  Third, 13C enrichment of the liver glycogen pool was assumed to be equal to 
the 13C enrichment of the carbohydrate of the ingested diet, 1.092 at%, once steady basal CO2 
13C 
enrichment had been reached (at day 3 in this study).
Chapter 4.5
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The rate of liver glycogen oxidation could then be calkculated as:
(measured 13C enrichment of CO2
 – basal 13C abundance of CO2)/(
13C enrichment of liver 
glycogen –basal 13C abundance of CO2)
Because the RQ for carbohydrate is 1 and the oxidation of 1mg of glycogen requires 0.829 mL of O2, 
the amount of labelled glycogen that was oxidized could be calculated as:
Glycogen (mg/min) = (rate of liver glycogen oxidation x CO2 consumption per min)/0.829
Comparison of the results with data from our previous studies:
We used historical controls from three of our previous studies. These studies had in common a 13C-
labelling period was 1 day and energy intakes of 80% of the required energy intake on prelabelling 
day 120% during the day of labelling.
The protocol of the study in which the repeatability of the breath test was studied was identical to the 
present study with the exception of the labelling period (Table I, study 24). In study 3 and 4 (Table I), 
no CO2 production was measured. In this comparison only the data from the European group study 
32 and from the non-cycling  group in study 43 were used. 
Statistical analysis
Mean values and standard deviations were calculated and compared with data from our previous 
studies. For comparison within the study group, paired t test was used. P < 0.05 was considered 
statistically significant. To compare between two different groups the two-sample t test was applied. 
P < 0.05 was considered to be statistically significant. 
RESULTS
13C-enrichment
At the start of the study (before breakfast at 8 a.m.) the 13C-abundance in breath CO2 was 1.0819 
(0.0005) at%. This value gradually increased during the following 3 d, when measured at the same 
point before breakfast. At day 2it was 1.0838 (0.0007); P < 0.001 versus day 1);  at day 3 it was 
1.0845 (0.0003; P <0.01 versus day 2); and at day 4it was 1.0845 (0.0006; not significantly different 
from day 3; Fig. 2). The postprandial 13C-enrichment data are shown in Figure 3. The maximum rise 
in breath 13CO2, 0.0065 (0.0011) at% excess, was reached 2.8 (0.4) h postprandially during day 3. 
The mean plateau level was 0.0030 (0.0001) at% excess. The end of plateau was observed at 14.8 
(1.2) h postprandially. The calculated return to baseline time was 25.8 (2.1) hours postprandial with 
a regression line correlation coefficient of 0.90 (0.06).
 
Blood glucose levels
During the fasting period the blood glucose levels initially were steady. However, after 14 h postpran-
dially, a significant decline in blood glucose level was observed (Fig. 4). 
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Glycogen oxidation rates
The glycogen oxidation rate calculated from the 13CO2 enrichment and the measured CO2 production 
are presented in Figure 5, left. For comparison, the results of our study 24 are presented in Figure 5, 
right. The oxidation rates in both studies correlated well for the first 17 h postprandially. After 17 h the 
rates were at least 10% higher in the 3-day labelling group (Fig. 6).
Comparison with the other 13C-breath test studies
In general the findings in the present study compare quite well with those of our previous studies. 
The end of plateau time and the return to baseline time were significantly shorter in study 2.4  The 
present results versus those of study 32  showed that the peak 13C enrichment and the 13C enrichment 
at plateau level were higher in the present study and the return to baseline time was significantly 
longer (Table I).
DATA OF THE PRESENT STUDY COMPARED WITH OUR THREE PREVIOUS STUDIES*
    present study Study 24 study 3²  study 4³
    ( n = 6 )  ( n = 12 )  ( n = 12 )  ( n = 6 )
Basal abundance (at%)  1.0819   1.0821   1.0820   1.0816 
    (0.0005)  (0.0006)  (0.0006)  (0.0007)
Maximum rise in enrichement 0.0065  0.0056  0.0048  0.0059
(APE)    (0.0011)  (0.0007)  (0.0010)  (0.0013)
Maximum rise in enrichement 2.83  2.67  2.67  2.20
 (h postprandial)   (0.41)  (0.65)  (0.98)  (1.20)
enrichement at plateau level   0.0030  0.0026  0.0020  0.0026
(APE)    (0.0001)  (0.0006)  (0.0007)  (0.0005)
End of plateau    14.3  12.5  13.5  12.8
 (h postprandial)   (1.20)  (1.51)  (1.17)  (1.17)
Return to baseline time  25.8  23.2  19.0  22.9
 (h postprandial)   (2.06)  (1.95)  (1.79)  (2.45)
*Data are expressed as mean (standard deviation). APE, atom percent excess; at%, atom percent
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Table 1.  Data of the present study compared with our three previous studies.  Data are expres-
sed as mean (standard deviation). APE, atom percent excess; at%, atom percent
* p value ≤ 0.01, # p value ≤ 0.05 using the two sample t-test.
Fig.4-5 1.  Outline of the study protocol.
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 13CO2 liver glycogen breath test afther prolonged labeling
Fig. 2.  13C-enrichment of breath CO2 after an overnight fast at the start of the study (study-day 1) 
and after the 13C-enriched diet had been consumed for 1, 2, and 3 d (study-day 2, 3 and 4).
Fig. 3.  13C-enrichment of breath CO2 in APE above baseline presented as mean and standar
deviation. The black dots ( ● )  represent the measured data, the open squares ( ❏ ) represent 
the calculated wash-out curve of the 13CO2 present at 4 hours postprandial and the open triangles 
( ∆ ) indicate the results of the subtraction of the wash-out curve from the measured data. Open 
triangles also represent the 13C-enriched liver glycogen oxidation. APE, atom percent excess; E, 
end of plateau time; R, return to baseline time. 
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Fig. 6.  Difference in liver glycogen oxidation rates (mg/min) between the 3-d labelling (n=6) and 
the 1-d labelling study4 (n=12). The 3-d labelling data were used as reference values. From 17 
hours postprandially onward, the difference was greater than 10% of the actual oxidation rate. 
Fig. 4.  Postprandial blood glucose levels measured every 3 h for 24 h starting 3 h after the last 
meal. Values are expressed as mean and standard deviation. *P ≤ 0.05 by t test when data are 
compared with the previous value in time.
Fig. 5.  Liver glycogen oxidation rates calculated from the data from the present, 3-d labelling 
study (n=6), and from the 1-d labelling study4 (n=12).  The study design for both studies was 
identical with the exception of the 13C-labelling time.
3-day labeling period
1-day labeling period
����
����
���
���
����
�����
�����
�� � ������������
�
��
�
��
��
�
��
��
�
��
��
�
��
�
��
�
��
�
��
�
��
�
��
��
��
��
�
��
��
�
��
��
�
��
��
�
��
��
�
��
��
�
��
��
�
��
��
�
��
��
�
��
��
�
��
��
�
��
��
�
��
��
�
boek_19-03-'03 19-03-2003, 15:5394
94 95
DISCUSSION
In our previous studies we explored the possibility of monitoring liver glycogen oxidation with a breath 
test and a diet of naturally 13C-enriched carbohydrate. The present study assessed the effect of pro-
longed, 3 d, labelling on the outcome of this breath test. The present 3-d and previous 1-d findings 
were compared.
The results of the present study showed a basal 13C-abundance at the start of the study that was 
within the range of the Dutch (West-European) population.2,8,11 While the subjects used the study diet, 
the fasting (8 a.m.) 13CO2 measurements showed an increase at days 2 and 3. A steady state was 
reached at day 3 (Fig. 2). This was in agreement with the presumption of the study design, which 
was based on the results of Gay et al.6 It indicated that, after 1 day of labelling, the 13C enrichment of 
liver glycogen is not yet maximal. It cannot be excluded that, after 3 or even 5 d of labelling, the core 
of the glycogen granules would not be fully labelled with 13C.6 It has been suggested that the core of 
the glycogen granules has a different pattern of metabolism.12
The means and standard deviations of the measured breath 13CO2 enrichment on day 4, the day of 
fasting after 3 d on a labelling diet, are shown in Figure 3, where the curve strongly resembles the 
curve we found in our earlier studies.1-4 The plateau level indicates a constant flux of enriched 13CO2. 
We interpret this as a constant liver glycogen oxidation rate during that period. The plateau phase 
and the decline in 13C-enrichment after 13 to 14 h postprandially are consistent findings in all our 
studies. 
However, the end of plateau time in the present study was later in one of the three comparative stud-
ies and the return to baseline time was later than in two of the three comparative studies. Thus the 
interpretation of the 13CO2 curve changed slightly with the longer labelling protocol.
After 17 h of fasting the blood glucose level showed a steady decline from 3.9 mM/L to 3.4 mM/L (Fig. 
4). We have no explanation for this phenomenon. However, it is an interesting observation because 
the decline in 13CO2 enrichment started simultaneously. Whether or not this is just a coincidence can 
only be guessed. The exact mechanisms through which hepatic glucose output (glycogenolysis and 
gluconeogenesis) are regulated are not completely clear.13 
The calculated glycogen oxidation rate compared well with the data from the previous study for the 
first 16 h postprandially (Figs. 5 and 6). The higher glycogen oxidation rates after 16 h fasting might 
be explained by a deeper penetration of the 13C-label into the glycogen granules after 3 d on a label-
ling diet. This would mean that after a 1-d labelling procedure the liver glycogen granules are not yet 
completely labelled. After an overnight fast the liver of a healthy individual still holds 70 to 150 gram 
of glycogen. Part of this will be consumed during the day, and glycogen formation will occur as soon 
as feeding starts again. Glycogen formation and glycogenolysis take place at the same time. Thus, 
after 1 d of consuming a 13C-enriched diet, a rather homogeneous mix of labelled and unlabelled 
glycogen can be expected.
In our original 1-d labelling protocol the day before the 13C labelling was administered, energy intake 
was restricted to 80% of the calculated energy need. This was done to achieve greater depletion of 
the liver glycogen pool during the subsequent night of fasting. The present study showed that such 
a restriction is not sufficient to reach a level of 13C-enrichment of liver glycogen that equals the 13C 
enrichment after 3 d on a labelling diet. Recent studies have suggested that a more extensively de-
pleted glycogen pool induces the uptake of glucose for glycogen formation.14,15  
The extent of mixing of ʻoldʼ and ʻnewʼ glycogen is still a matter of debate.16 
Some studies have suggested a last-in first-out pathway,17,18 but other studies do not confirm this.16,19-
21
Do these findings have consequences for the future design of a glycogen-consumption breath test? 
The present findings indicated that, with the 3-d labelling period, a higher 13C-enrichment of liver 
glycogen is reached. This is reflected in a slightly higher glycogen oxidation rate. The absolute dif-
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ferences are rather small, however, and observed only after 17 h postprandially. Whether this dif-
ference will be relevant in the clinical interpretation of the test results will have to be shown in future 
(patho-) physiological studies. The 3-d labelling protocol certainly makes the test longer and more 
cumbersome.
We compared the present results with those of some recent studies that focused on liver glycogen 
depletion. The overall glucose production is usually agreed to be about 2 mg � kg-1 � min-1 in healthy 
adults. This corresponds to 140 mg � min-1 for a 70 kg person. In our study the estimated glycogen 
oxidation was 55 mg/min over 6 to 12 h postprandially. This amounts to 40% of those 140 mg/min. 
The contribution of gluconeogenesis must therefore be about 60%. This last figure fits well with the 
estimates for gluconeogenesis in the NMR study of Peterson et al. of 55 ± 6% between 6 and 12 h.22 
Hundal et al., estimated a contribution of gluconeogenesis to glucose output of 50% by NMR and 
about 50% by the D2O technique over 15 h.
23 Gay et al., who also performed breath test studies, de-
scribed a contribution of gluconeogenesis of 51 ± 5%.6 These results from the literature accord well 
with our findings concerning liver glycogen oxidation rates in this study.
Of the presently available techniques to measure liver glycogen content, NMR seems to be the 
most direct one. It could be considered the current gold standard. With repeated NMR studies, net 
changes over time in glycogen content can be measured. In combination with other techniques such 
as stable isotope studies of the total glucose production and the rate of gluconeogenesis, the kinet-
ics of liver glucose metabolism can be further delineated.18,22,23 The 13CO2 breath test only measures 
the oxidation of labelled liver glycogen. Simultaneous synthesis of glycogen or gluconeogenesis 
from non-labelled substrate could occur. If such non-labelled glycogen or non-labelled glucose syn-
thesized through gluconeogenesis is subsequently oxidized during the breath test, this will not be 
detected. Indeed, the 13CO2 breath test only measures the oxidation of 
13C-enriched glycogen that 
is present in the liver at the end of the labelling period. However, because no significant cycling has 
been observed in fasting healthy subjects,18 the breath test might be a valid clinical tool to study the 
contribution of liver glycogen to energy availability and production under fasting conditions. 
It would be interesting to make a direct comparison between the 13CO2 breath test as a tool to study 
liver glycogen metabolism with the NMR technique and the isotope measurements of total glucose 
production and gluconeogenesis.
Obviously, there could be some 13C contamination in other energy sources such as fat or protein that 
could contribute to 13C-labelled CO2 production under fasting state conditions. This phenomenon is 
probably reflected in the basal 13C enrichment if the CO2 pool that is not solely dependent on labelled 
carbohydrate oxidation. However, Gay et al. demonstrated that the 13C abundance of plasma pro-
teins and very low-density lipoproteins remains constant even during 5 d of use of a 13C-enriched 
labelling diet.6 Thus, we believe that the oxidation of labelled substrates other than liver glycogen is 
not a problem in our study design.
The breath test has the advantage of being a rather simple, investigatory tool suitable for clinical 
application. In this context and for practical reasons, a 1-d labelling period might be preferable to a 
3-d diet. 
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A 13CO2 breath test to assess liver glycogen oxidation.
An orientation in patients with cirrhosis of the liver.
A.A. Tanis, J.W.O. van den Berg, T. Rietveld, J.L.D. Wattimena and G.R. Swart.
Part of this study has been published in “Advances in hepatic encephalopathy & metabolism in liver 
disease”. Eds. Christopher Record and Hanan Al-Mardini. ISA 1996, Medical Faculty, University of 
Newcastle upon Tyne, Newcastle upon Tyne. Chapter 7. “Depletion of liver glycogen in cirrhosis us-
ing a 13C-enriched diet and 13CO2 breath samples”, AA Tanis, JWO van den Berg, T Rietveld, JLD 
Wattimena and GR Swart. 
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Abstract
In a pilot study the 13CO2 breath test to assess liver glycogen oxidation was applied in 12 healthy 
volunteers and 12 patients with advanced liver cirrhosis. Patients with liver cirrhosis are thought to 
have a small liver glycogen pool, resulting in a more rapid change from glycogenolysis to gluconeo-
genesis during fasting. We used the blood glucose response to intravenous glucagon as an indicator 
of  reduced hepatic glycogen storage. The insulin : glucagon ratio was monitored in the postprandial 
period in both patients with cirrhosis of the liver and in healthy subjects. Both insulin and glucagon 
values were increased in cirrhosis. However the insulin : glucagon ratio was lower in cirrhosis. After 
10 hours fasting this ratio could be used to discriminate between the two groups.
The 13CO2 enrichment was higher in the patients with cirrhosis at the time of 6 hours postprandial.
The decline in 13CO2 between six and fourteen hours postprandial was more in the patients with cir-
rhosis. Glucose response to glucagon was lower in cirrhotics than in healthy controls.
The combination of insulin : glucagon ratio and decline in 13C-enrichment of breath CO2 could be a 
tool to select patients for further metabolic studies or clinical intervention.
Introduction
In chapters 3 and 4 a new method to examine hepatic glycogen oxidation and thus indirectly hepatic 
glycogen reserves is described. Patients with liver cirrhosis are believed to have smaller hepatic gly-
cogen stores than healthy individuals, and this results in depletion of the glycogen pool at an earlier 
stage during fasting and in an earlier increase of gluconeogenesis to maintain an adequate blood 
glucose level. [1]
We therefore decided to compare the results of the 13CO2  breath test in patients, who could be pre-
dicted to have a small liver glycogen pool,  with healthy controls. Patients with advanced cirrhosis of 
the liver (Child-Pugh classification B and C) were chosen.  As an indirect confirmation of the small 
hepatic glycogen pool in this category of patients, we measured the blood glucose response to a 
standard dose of glucagon after a 15 hour fast. If after fifteen hours of fasting the glycogen pool in 
patients with cirrhosis is depleted to a greater extent than in controls, then the increase of the blood 
glucose level after i.v. administration of glucagon is predicted to be less marked. [2]
The study was perfomed as a pilot study to compare the changes occurring in carbohydrate me-
tabolism during fasting in patients with liver cirrhosis with those in healthy controls. We analysed the 
blood levels of different molecules involved in glucose and glycogen metabolism in twelve healthy 
volunteers and in twelve patients with cirrhosis during a two to fifteen hour postprandial period. 
The hepatic metabolism of glucose and glycogen is mainly regulated by hormones. Although there 
is a demonstrable neuronal influence, this probably plays a minor role as after liver transplantation 
glucose and glycogen metabolism is not greatly disturbed. [3] The two key hormones involved in the 
regulation of glucose and glycogen metabolism are glucagon and insulin. The ratio of these two hor-
mones is of importance in determining if there is a net glycogenesis or a net glycogenolysis. [1,2,4] 
The insulin: glucagon ratio was determined repeatedly during the fasting period.  We postulated that 
the insulin:glucagon ratio would be lower or decrease at an earlier stage during fasting in patients 
with cirrhosis . Blood glucose levels were expected to be higher in cirrhosis since many patients with 
cirrhosis have a relative insulin resistance. 
We postulated that patients with cirrhosis of the liver have a smaller liver glycogen pool. We assumed 
that, before administering the 13C-enriched diet, this pool is at least as empty as in healthy controls.
Should the liver glycogen reserves in cirrhotics be depleted to a greater extent by  the dietary restric-
tion before loading with 13C-enriched carbohydrates, then  the  relative 13C-enrichment of the glyco-
gen pool will be higher in patients with liver cirrhosis, and this will be reflected  by a higher 13C-enrich-
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ment at plateau level. In this study the 13CO2 enrichment at 6 hours postprandially was considered to 
represent the plateau in both groups.
Several studies have emphasised that postprandial protein depletion starts early in cirrhosis, and the 
most likely explanation is that this is to compensate for an early depletion of the liver glycogen pool. 
[1,4-6]. We  therefore postulated that a smaller liver glycogen pool which is depleted at an earlier 
stage during fasting will result  in a steeper decline in the 13CO2 enrichment of breath CO2  in patients 
with cirrhosis of the liver. 
Study subjects and methods
Subjects
Twelve healthy volunteers and twelve patients with cirrhosis of the liver and a Child Pugh classifica-
tion B (8-9 points) and C (10 points) participated in the study. The cirrhosis was biopsy-proven in all 
patients. 
Study protocol
The healthy volunteers did not use any medication and consumed less than two units of alcohol per 
day. Patients known to have diabetes mellitus were excluded. One patient, who was initially included, 
received insulin treatment and her data were not used in the analysis. All participants gave informed 
consent.
All participants received a standard diet during the day. The details of the diet have been described 
elsewhere. [7] Three meals were consumed during the day. The last meal was taken at 6 pm.
Blood samples for the analysis of glucose, glucagon, insulin, alpha-amino-acids, beta-hydroxy-
butyrate, free fatty acids and alanine were drawn at 8pm, midnight, 4am, 8am. (two, six, ten and 
fourteen hours postprandially).  At 9am (fifteen hours postprandially)  blood  was taken to measure 
glucose and 1mg glucagon (Novo, The Netherlands) was administered via an antecubital vein. Blood 
samples were taken 10, 15 and 20 minutes after the injection. Glucose was analysed in these 4 blood 
samples.
Methods
Standard hospital laboratory techniques were used for the analysis of the hormones and metabo-
lites.
The molar insuline:glucagon was calculated as:
(insuline in mMol/l : glucagon nanogramm per liter )*23.3 [8]
For the 13CO2 breath test all participants followed the same protocol. This protocol has been de-
scribed  in detail elsewhere [7]  The day before the 13C-enriched diet was consumed all used a stand-
ard diet, which contained 80% of the calculated daily energy need. The 13C-enrcihed diet supplied 
120% of the calculated energy need. The diet was consumed during three meals. The last meal was 
taken at 6pm. Breath samples were taken at regular intervals till 9am the next morning (15 hours 
postprandial). 
Chapter 5
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Statistical analysis 
The mean and standard deviation of each group was calculated for each parameter. Since the two 
groups were not matched, the Mann-Whitney test (Wilcoxon two sample test) was used to compare 
the two groups. A p-value of < 0.05 was considered to be significant.
For paired data the student T-test for paired data and two-sided variance was used.  A p-value of < 
0.05 was considered to be significant.
An orientation in cirrhotic patients
Table 1:  Data from patients (n=11) and  volunteers (n=12) expressed in mean (SD), in hours postprandial with the excep-
tion of the  rise  in glucose concentration.
Item   h postprandial Patients  Volunteers  p value
Glucose (mmol/l)            2  7.1 (3.6)  4.5 (0.8)   < 0.001
             6  6.1 (3.4)  4.2 (0.3)   < 0.05
           10  5.0 (2.2)  4.1 (0.4)   NS
           14  4.4 (1.3)  4.2 (0.5)     NS
           15  4.8 (1.4)  3.9 (0.5)   NS
Rise glucose (mmol/l)     10 min          - 0.1 (0.8)  0.5 (0.7)   NS
In minutes after glucagon     15 min  0.1 (0.8)  1.2 (1.0)   < 0.02
       20 min  0.4 (0.9)  1.6 (1.1)   < 0.02
Insulin mU/l            2  56.5 (15.9) 32.9 (20.6)  < 0.01
             6  31.9 (14.7) 13.4 (12.0)  < 0.001
           10  18.7 (6.7)  13.1 (10.4)  < 0.01
           14  17.2 (6.7)  13.2 (4.3)   NS
Glucagon ng/l            2  125.9 (114.9) 32.9 (14.7)  < 0.01
             6  92.1 (83.8) 15.8 (5.7)   < 0.01
           10  105.0 (76.2) 14.8 (10.0)  < 0.001
           14  103.5 (91.5) 14.8 (12.6)  < 0.001
Molar insulin / glucagon           2  23.1 (31.9) 33.7 (35.5)      NS
             6  22.6 (35.5) 21.6 (20.0)      NS
           10  5.2 (1.9)  28.5 (24.9)  < 0.001
           14  4.5 (2.2)  32.2 (22.8)  < 0.001
 
a-amino-N            2  4.5 (0.5)  5.0 (0.7)       NS
             6  4.0 (0.5)  4.6 (0.5)   < 0.01
           10  3.9 (0.5)  4.3 (0.4)   < 0.05
           14  3.7 (0.4)  4.3 (0.5)   < 0.02
beta-OH-butyric acid           2  19.5 (6.4)  47.1 (35.9)  < 0.01
             6  49.7 (39.4) 167.5 (89.7)  < 0.001
           10  66.0 (39.6) 158.9 (92.2)  < 0.01
           14  109.1 (49.3) 162.6 (116.4)      NS
free fatty acids            2  303.6 (121.7) 689.2 (590.2)  < 0.02
             6  496.4 (351.5) 725.8 (302.2)      NS
           10  711.8 (342.7) 575.0 (203.1)      NS
           14  959.1 (170.9) 690.0 (273.3)      NS
alanine             2  409.1 (61.7) 358.3 (81.6)      NS
             6  320.9 (69.2) 300.0 (41.3)      NS
           10  281.8 (60.0) 269.2 (33.7)      NS
           14  276.4 (63.6) 310.0 (66.1)      NS
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Results
One patient, who was initially included, had an insulin dependent diabetes mellitus. The data from 
this patient were excluded from the analyses. Thus data from twelve volunteers and eleven patients 
were analysed. 
The mean (± standard deviation) age of the patients group was 58.6  ± 8.9 years and of the healthy 
volunteers 36.2 ± 5.8 years (p<0.01). The mean height of the patients was 173.6 ± 7.4 cm and of the 
volunteers 178.6 ± 9.9 cm (n.s.). The mean weights were respectively 72.3 ± 12.6 kg and 75.5 ± 10.0 
kg  (n.s.) and their body mass indices were 23.9 ± 3.7 and 23.6 ± 2.2 kg*m-2  (n.s.).
Though the age was significantly different between the two groups, body height, weight and body 
mass index were not. The patients had no ascites detectable by physical examination during the 
observation period.
The other data are presented in table 1.
Blood glucose levels were different in the early postprandial phase, two and six hours after the last 
meal. One patient had blood glucose values exceeding 10 mMol/l two, six and ten hours postprandi-
ally.
Exclusion of the data of this patient changed the significance of the difference from p < 0.05 to p > 
0.05 at six hours postprandially. No change was observed at the other points in time.
The increase in blood glucose concentration in response to the glucagon injection was higher in the 
volunteers fifteen and twenty minutes after the glucagon injection.
Insulin levels were higher in the patient group the first ten hours postprandially, while the glucagon 
levels stayed higher throughout the observation period.
The alpha-amino acids levels were lower in the patient group, except at two hours postprandially. In 
contrast, beta-hydoxybutyrate levels differed during the early postprandial hours, while free fatty acid 
concentrations showed little difference. The alanine levels did not differ significantly between the two 
groups throughout the period of observation. 
Table 2:  The molar insulin : glucagon ratio of 11 patients with cirrhosis (P) and 12 healthy vo-
lunteers (V). In the left column the data were divided above 10 and below 10, while in the right 
column the data were divided above 15 and below 15. Data were collected 2, 6, 10 and 14 hours 
postprandially (pp). 
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10 hours postprandial
insulin:glucagon   ratio    patients    volunteers    total  insulim:glucagon    ratio    patients    volunteers    total
           =< 10          11                       2                 13                   =<15                11                    8             19
 >10            0                     10                 10        >15                  0                     4               4
totaal           11                     12                23                        11                  12             23
sensitivity       100      sensitivity             100
specificity               83.3  specificity                       33.3
14 hours postprandial
insulin:glucagon   ratio    patients    volunteers    total  insulim:glucagon    ratio    patients    volunteers    total
           =< 10          10                        1                11                   =<15                10                    3             13
 >10             1                     11               12        >15                   1                    9             10
totaal           11                     12                23                        11                  12             23
sensitivity       90.9      sensitivity             90.9
specificity               91.7  specificity                       75.0
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The individual molar insulin : glucagon ratios are depicted in figure 1. 
After 10 hours a ratio of 10 was found to be a cut off point between the two groups. The only person 
with a ratio above 10 in the cirrhosis group had a ratio of 228, which is extremely high. This outlying 
value has been excluded in the data presented in figure 1 but was included in the analysis presented 
in table 2.
The relation between the rise in blood sugar after glucagon injection and the insulin : glucagon ratio 
is shown in figure 2 .
The 13C-enrichment of breath CO2 at plateau level (6 hours postprandial) was 0.00431 ± 0.00152 
APE in the patient group and in the healthy group 0.00276 ± 0.00094 APE, p <0.05. Figure 3.
The decline in 13CO2 enrichment between 6 and 12 hours was for patients –0.00174 ± 0.00096 APE 
and –0.00105 ± 0.00061 APE in controls  (n.s.). 
The decline in 13CO2 enrichment between 6 and 14 hours was for patients –0.00264 ± 0.00089 APE 
and in controls –0.00136 ± 0.00058 APE (<0.01). 
The decline in 13CO2 enrichment between 6 and 15 hours postprandial was for patients –0.00293 ± 
0.00105 APE and in controls –0.00184 ± 0.00064 APE (<0.05.) 
See figure 4.
The combined data of the insulin : glucagon ratio and the decline in 13CO2 in both groups are shown 
in figure 5. The two groups are well separated by the combination  of these two parameters.
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Figure 1:  The molar insulin : glucagon ratio in 11 patients and 12 volunteers at 2, 6, 10 and 14 
hours postprandial.
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Figure 2:
The relationship between the molar insulin : glucagon ratio fourteen hours postprandial and the 
increase in blood glucose level after administration of 1 mg glucagon iv  in healthy subjects (tri-
angles) and cirrhotics (open dots). Data of one patient who had a extreme high ratio of 288 has 
been omitted.
Figure 3:
The 13C-enrichment of breath CO2 in atom percent excess six hours postprandial in twelve he-
althy volunteers (vol) and eleven patients with cirrhosis (pat). The horizontal bar represents the 
mean value in each group.
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Figure 4:
Decline in 13C-enrichment of breath CO2 in atom percent excess (APE) during the period from six 
to fifteen hours postprandial (pp) in cirrhotic patients and healthy controls.
Figure 5:
Relationship between the decline in 13C-enrichment of breath CO2 in atom percent excess over 
the period six to fourteen hours postprandial and the molar insulin : glucagon ratio at fourteen 
hours postprandial in 10 patients and 12 healthy controls. Data from one patient with a ratio of 
288 has been omitted.
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Discussion
Elevated blood glucose levels are often observed in patients with cirrhosis. [1,9] An decreased insulin 
sensitivity of the peripheral tissue could contribute to this phenomenon. In our study we only found 
significantly raised blood glucose levels in one patient, as we excluded patients treated for hyperg-
lycaemia from the study. 
The reduced glycemic response to glucagon injection in patients with cirrhosis has been ascribed to 
depletion of hepatic glycogen stores and is similar to that found in healthy volunteers after 3 days of 
fasting. [1,10]  Kabadi found a increase in blood glucose after an intravenous bolus of 1 mg glucagon 
of 3.58 ± 0.22 mmol/l in healthy volunteers and 1.45 ± 0.21 mmol/l in cirrhotics after an overnight fast. 
They measured the increase of glucose from fasting level till the highest level measured in a period be-
tween 15 and 180 minutes after 1 mg glucagon intravenously, 9 measuring points [2] Zillekens reported 
an increase of 2.35 ± 0.19 mmol/l in healthy volunteers and 0.79 ± 0.08 mmol/l in cirrhotics. [1] 
Hyperinsulinemia in cirrhosis has been documented in many studies and is attributed by some au-
thors to an increased production of insulin, while others have reported a decreased clearance of 
insulin. The hyperglucagonemia is thought to be caused by hypersecretion. [1,6,9]
An interesting observation was the decrease in insulin levels over time while the glucagon levels 
hardly changed. This supports the suggestion that the higher levels are a result of an increased pro-
duction rather than of an impaired clearance. 
Marchesini suggested that the decreased insulin/glucagon ratio would enhance muscle protein ca-
tabolism, which they found to be increased in cirrhotics. [4] In contrast Fabri did not find an increase 
in hepatic nitrogen metabolism after glucagon infusion in patients with cirrhosis. [9] Swart found a 
negative correlation between the nocturnal protein loss and the increase of the serum glucose level 
after a standard dosage of glucagon given intravenously after an overnight fast. A higher protein loss 
correlated with a lower increase in serum glucose concentration, r2 = 0.79, p 0.05 (personal com-
munication)  
Plasma free fatty acid levels increased in patients after 14 hours of fasting. Zillekens and co-work-
ers also found a higher level of plasma free fatty acids in cirrhosis, and suggested that the higher 
free fatty acid level could be due to a decreased hepatic removal in cirrhosis. [1] However an early 
depletion of the liver glycogen pool could initiate a stimulation of lipolysis and an increased contribu-
tion of oxidation of free fatty acids to energy production. The levels of ß-hydroxybutyrate were lower 
in patients with cirrhosis up to and including the ten hours postprandial measuring point. Zillekens 
observed no difference after an overnight fast. This emphasizes again the importance of multi-point 
measurements. The interpretation of the differences can only be speculative since turnover studies 
were not performed.  It is possible that the liver , which is the only organ to add significant quantities 
of ketone bodies to the blood, has a higher fatty acid oxidation rate during these hours, or that the 
utilization of ß-hydroxybutyrate by extrahepatic tissues is relatively reduced. [11] 
The blood levels of alpha-amino acids were higher in the control group but the alanine levels were 
not different. Zillekens found the opposite in the fasting state. Alanine is a main source for gluco-
neogenesis. Again only turnover studies will provide answers on metabolic questions concerning 
substrate utilization. No rise in alanine levels does not necessarily mean that alanine utilization is not 
increased.
The insulin : glucagon ratio observed in this study suggests that the ratio may help to detect patients 
with the metabolic abnormalities at risk for early protein depletion in cirrhosis. If this observation 
is confirmed by future studies this could be an easy parameter to correlate with other metabolic 
changes. Previous studies have shown a wide variation in both glucagon and insulin values. In the 
study of Zillekens, glucagon was 23 ng/l in healthy volunteers and 266 ng/l in patients with cirrhosis. 
The insulin values were 5.7 and 17.5 mU/l respectively. The molar insulin : glucagon ratio was found 
to be significantly lower in cirrhosis. [1]
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Almdal measured a glucagon value of 85 ng/l and an insulin value of 6.8 mU/l in healthy volunteers, 
[12] while Vilstrup reported a glucagon level of 75 ng/l and an insulin level of 10 mU/l. [5]
Kabadi found in healthy controls a glucagon of 173 ng/l and in cirrhotics 487 ng/l together with an 
insulin level of 7 mU/l in controls and 18 mU/l in cirrhosis. [2] 
All reported that the blood-samples were taken after an overnight fast. The great variation will be a 
drawback in using insulin : glucagon ratios for the individual patient unless the blood samples are 
taken under strictly standardized dietary and time conditions. 
The relation between the increase of blood glucose and the molar insulin ratio is shown in Figure 2. 
Kabadi showed an inverse relation between the glucagon level and the response to glucagon injec-
tion during fasting. As expected this relation is even more clear when related to the insulin : glucagon 
ratio. [2] 
The study is in agreement with the hypothesis that the 13C-enrichment of breath CO2 would be higher 
in patients with cirrhosis at the time of the plateau level. 
It can be argued that in liver cirrhosis gastric emptying could be delayed and that therefore the 13C-
enrichment of the breath CO2 would not only be derived from liver glycogen but also from delayed 
absorption of carbohydrates from the intestine. We did not measure stomach emptying. However if 
delayed absorption were to play a role then the 13CO2 curve should increase more slowly and reach 
a top at a later stage. This was not observed. 
The insulin : glucagon ratio discriminates quite well between the two groups. If combined with the 
13CO2 decline the discrimination becomes even better.
If further studies confirm these findings the combination of the breath test and the insulin : glucagon 
ration could be used in clinical practice, for instance to decide whether specific nutritional interven-
tions such as late night carbohydrate supplementation are necessary [1]  
We thank JHP Wilson for helpful discussions and a critical revision of an earlier draft of the paper.
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In the body carbohydrate is stored as glycogen in liver and skeletal muscle. The glycogen is used on 
demand as a source of glucose and it is replenished after a meal.
In the interpretation of previous research it was postulated that patients with cirrhosis of the liver 
have a smaller liver glycogen pool. As a result of an earlier depletion of the glycogen pool, gluco-
neogenesis would be enhanced in cirrhosis during relatively short term fasting – like overnight. This 
enhanced gluconeogenesis could be the cause of a more negative nitrogen balance, as had been 
observed in cirrhosis.
While the studies described in this thesis were being performed, Peterson et al confirmed this hy-
pothesis by an elegant study in which they combined NMR and stable isotope techniques. [1] 
We wished to develop an easy bedside method to study liver glycogen kinetics, especially liver gly-
cogen depletion.  We designed a theoretical model on which to base our test, taking into account the 
availability of a mass spectrometer, experience with 13C-isotopes and our limited budget. This model 
was tested in healthy volunteers. 
We developed the following method.
The liver glycogen pool of persons, who are used to a low 13C-enriched West-European diet, is 
depleted during an overnight fast. They then are given a naturally 13C-enriched carbohydrate diet to 
replete the liver glycogen pool with naturally 13C-enriched carbohydrate.
During subsequent fasting the enriched glycogen is used as a source of glucose and is oxidized. This 
oxidation enriches the body CO2 pool with 
13C and thus the 13CO2 proportion of breath CO2 increases. 
This breath CO2 can easily be collected and the 
13C-enrichment can be measured.
Since muscle glycogen is hardly utilised under sedentary conditions the sole source of 13C-enrich-
ment will be the enriched liver glycogen. 
Different aspects of the proposed method were tested.
The stability of the baseline 13CO2 values, essential for this kind of studies, was shown in chapter 3. 
The mean 13C-abundance of breath CO2 was 1.0828 SD 0.00082. The distribution of the data fol-
lowed a normal distribution pattern. Repeated measurements showed a small and acceptable varia-
tion in day to day measurements and after 3 months.
We concluded that the baseline 13C-abundance is stable and can be used as a baseline value in this 
study-design. 
A matter of concern could be the increasing trend in Europe to use imported foodstuffs from all over 
the world.  This makes it necessary to measure baseline 13C-abundance in every single study sub-
ject. 
The studies reported in chapter 4 show that it is possible to measure in a reliable fashion the slight 
differences in 13C-enrichment that we induce in our model. This made an interpretation of the 13CO2 
enrichment data possible. The observation that a plateau in 13C-enrichment could be observed for 
some hours is very interesting. Knowing that the only 13C-enrichment excess above baseline comes 
from liver glycogen it strongly suggests a constant oxidation of enriched liver glycogen. This can only 
be concluded if the CO2 excretion rate remains constant during the observational period.
The later studies confirmed that the CO2 excretion rate is indeed quite constant during the plateau 
period.
The end of plateau time is another interesting point. At this time something changes. Again assuming 
Summary and concluding remarks
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a constant CO2 excretion rate the change in 
13C-enrichment indicates a change in substrate that is 
used for oxidation. In more specific terms, it means that instead of 13C-enriched carbohydrate non-
13C-enriched substrate is now being oxidized. This could mean an enhanced gluconeogenesis. 
Based on the literature we assumed that the muscle glycogen does not interfere with the breath test 
as long as study subjects are sedentary. This was confirmed by a study in which this was specifi-
cally tested. Healthy volunteers depleted a substantial part of their muscle glycogen pool by intense 
exercise prior to consuming the 13C-enriched food. It was shown that muscle glycogen was enriched 
through the use of the diet, but that it did not interfere with the test results as long as the subjects 
stayed sedentary.
We investigated the hypothesis that it must be possible to carry out the designed test in the inverse 
version in persons used to a 13C-enriched diet. Africans used to a diet with the naturally 13C-enriched 
corn and sorghum as staple food, received a West-European diet for one day and breath CO2 sam-
ples were collected for 13C-enrichment analysis. The hypothesis was confirmed. Inversed curves 
were observed. However the 13C-enrichment of the CO2 pool did not completely return to the starting 
values, probably because of a slightly lower 13C-enrichment of the fat and protein pool.
In order to be useful, a test should be reproducible. Although this seems obvious Altman complained: 
“Replicate studies are rarely made in method comparison studies, so that an important aspect of 
comparability is often overlooked. A method with poor repeatability will never agree well with another 
method.” [2] 
Our reproducibility study showed that the designed method showed an acceptable reproducibility. 
Compared with the indirect calorimetry method to analyse carbohydrate oxidation, the oxidation rate 
that was calculated from the 13CO2 breath test data was lower. A possible explanation could be the 
relatively large and slow reacting nitrogen pool in the calorimetry studies. Another possible explana-
tion could be an incomplete or lower 13C-enrichment in the liver glycogen pool in our studies.
Incomplete labelling of the liver glycogen pool after an only one-day labelling diet could influence the 
results. Our fifth study showed that after a three-day labelling diet there seemed to be a slightly more 
extensive labelling of the liver glycogen pool. The end of plateau phase and the return to baseline 
time were significantly longer in the three-day labelling group. However the difference that was ob-
served between the two groups was rather small. The question is whether this difference is clinically 
relevant and warrants the advice to always use a three-day labelling in future studies. Preparatory 
to answering this question our method should be compared with another method, such as the NMR-
method.
A requirement for a comparison of the method described in this thesis with the NMR-technique is that 
no cycling occurs during the observation period, since the described 13CO2 method does not take 
cycling into account, while the NMR method measures the net disappearance of liver glycogen.
Some orientation data were collected from patients with a biopsy proven cirrhosis of the liver and 
reported in chapter 5. 
Although the model appears to be a valid representation of liver glycogen oxidation during fasting 
and might be useful for measuring glycogen depletion in the liver of healthy individuals, other factors 
can complicate the interpretation in patients with liver disease.
A smaller glycogen pool at the start of the enrichment period in a patient with cirrhosis will produce 
a 13C-enrichment of the liver glycogen pool that is higher or at least equal to the healthy controls. 
Oxidation of this glycogen would results in a higher or at least an equal 13C-enrichment of breath 
CO2. However a relatively increased contribution of gluconeogenesis towards oxidation of glucose 
will cause the 13C-enrichment to be lower. From this point of view an even and maximal enrichment 
of the liver glycogen should be the starting-point for all subjects.
Chapter 6
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If such an maximal 13C-enrichment of the liver glycogen is achieved the variation in breath 13CO2 will 
be due to the relative contribution of oxidised 13C-enriched liver glycogen.  
The orientation showed a higher 13C-enrichment at plateau level, a steeper decline in 13C-enrichment 
over the period 6 to 14 hours postprandial. The combination of this decline in 13C-enrichment and 
the molar insulin : glucagon ratio gave a clear discrimination between the healthy controls and the 
patients with cirrhosis. This set of data could provide a useful tool to select patients for nutritional 
intervention or further studies.
In conclusion we developed a model to monitor the oxidation of liver glycogen. Our studies showed 
that it was possible to label the liver glycogen with naturally 13C-enriched carbohydrate and to monitor 
its oxidation. 13C-enriched muscle glycogen did not interfere with the test within the test conditions. 
The test design and the tests results were confirmed by using the inverse test set-up in persons who 
were used to a habitual diet of 13C-enriched carbohydrates. The test was reasonably reproducible 
within the same persons, though the study group was small. Extending the dietary 13C-enrichment 
from one to three days did alter the test results. These alterations were small and possibly of no clini-
cal importance. 
A pilot study shows that the test indeed is capable of detecting differences in glycogen oxidation 
between cirrhotics and healthy individuals.
The clinical application of the test needs further validation by comparing it with other techniques such 
as the NMR. 
The studies described in this thesis demonstrate the feasibility of using naturally isotope enriched 
products for metabolic studies. This breath test is relatively simple to perform as a bedside test and 
makes use of inexpensive substrates. For a metabolic test to evaluate a complex process, it is rea-
sonably reproducible. 
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Vrijwel alle koolhydraten, die het lichaam opneemt, worden omgezet in glucose.
Van dit glucose wordt 98% gebruikt voor energie productie (verbranding).
Dit kan op twee manieren. Of glucose wordt direct opgenomen in de lichaamscel en daar gebruikt 
of het wordt eerst opgeslagen als glycogeen, om later weer te worden gemobiliseerd en verbrand. 
Deze opslag gebeurt in lever- en spiercellen.
Als er een tekort aan glucose dreigt, dan wordt glycogeen weer omgezet in glucose.
Bij een tekort aan glycogeen vormt het lichaam glucose uit glycerol uit vet en uit aminozuren afkom-
stig van eiwitten (gluconeogenese). Als de glycogeen voorraad klein is, dan zal het proces van glu-
coneogenesis eerder een rol van betekenis gaan spelen. Deze eerder optredende gluconeogenese 
kan zo een verhoogde eiwitafbraak in het lichaam veroorzaken.
Om in de klinische praktijk inzicht in het proces van glycogeenverbruik tijdens vasten te verkrijgen is 
een relatief eenvoudige test nodig om de verbranding van glucose uit het leverglycogeen zichtbaar 
te maken.
De in dit proefschrift beschreven studies betreffen het ontwerp en het toetsen van een methode om 
de verbranding van leverglycogeen te kunnen volgen.
Hierbij werd gebruik gemaakt van een op natuurlijke wijze met 13C-verrijkte koolhydraten. Dit wordt 
gevormd via een in de natuur uniek fenomeen van isotopische discriminatie bij de opbouw van plan-
taardige koolhydraten. 
In de natuur komen twee stabiele isotoopvormen van het koolstof atoom (C) voor, namelijk 12C en 
13C. In de atmosfeer komen de twee isotopen van het koolstofatoom voor in de verhouding 12C 
(98,9%) en 13C (1,1%).
Gedurende de koolhydraatsynthese treedt een isotopische discriminatie op ten gunste van het 12C 
atoom. Het percentage 13C is dan niet meer 1,1% maar slechts 1,08%. 
Een uitzondering hierop zijn plantensoorten die hun koolhydraten via een ander chemisch pad syn-
thetiseren. Het percentage 13C in de koolhydraten van deze planten is vrijwel gelijk aan de atmosfeer. 
De meeste plantensoorten, die dit pad gebruiken, komen in de tropen voor. Voorbeelden van deze 
planten zijn maïs, rietsuiker, sorghum, millet en ananas.
Het verschil in 13C percentage is klein, doch zeer stabiel. 
In alle overige metabole processen, zoals bij opslag en verbranding in het menselijk lichaam, treedt 
geen isotopische discriminatie meer op. Derhalve is het mogelijk om dit natuurlijk verschil te ge-
bruiken in metabole studies bij mens en dier.
De meeste planten in de voedselketen in West-Europa, hebben een lage 13C-verrijking. Dit werkt 
door in de totale 13C-verrijking van de voeding, bijvoorbeeld ook het vlees en de melk. 
Dit heeft als gevolg, dat de stoffen die het lichaam verbrand ook een lagere 13C-verrijking hebben en 
dus heeft ook het bij deze verbranding gevormde koolzuurgas (CO2) een lagere verrijking. Het door 
verbranding gevormde koolzuurgas verlaat het lichaam voornamelijk via de uitademinglucht. Het 13C-
gehalte van dit koolzuurgas kan dus in de uitademinglucht worden gemeten.
Slechts als bijvoorbeeld suiker of snoep uit suikerriet, cornflakes of vlees van maïsgevoede kippen 
wordt geconsumeerd, krijgt de West-Europeaan koolhydraten, eiwitten en / of vetten van hogere 13C 
verrijkingsgraad binnen. Als nu voedsel met een hogere 13C-verrijking wordt verbrand, dat is dit te 
meten door de stijging in de 13C-verrijking van de uitgeademde CO2. 
Samenvatting
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Dit concept werd door ons toegepast in een studieontwerp om de verbranding van leverglycogeen 
te bestuderen.
Het studieontwerp werd gebaseerd op de volgende overweging.
Tijdens vasten in rust wordt de glucose concentratie in het bloed op peil gehouden door afbraak van 
leverglycogeen en de nieuwvorming van glucose uit vet of eiwit.
Als nu het leverglycogeen als enige een hogere 13C verrijking heeft, zal een verhoging van het 13C 
gehalte in de uitademinglucht plaatsvinden als glycogeen uit de lever wordt verbrand. 
 Wordt er dus een extra verrijking in adem CO2 gemeten, dan is dit afkomstig van glucose gevormd 
uit leverglycogeen. De bijdrage van 13C-verrijkt leverglycogeen kan op deze manier redelijk eenvoud-
ig worden gevolgd door tijdens rustend vasten op verschillende tijdstippen ademlucht te verzamelen 
en dit te meten op 13CO2 verrijking.
Er werden een aantal oriënterende studies uitgevoerd. [hoofdstuk 3] In de eerste plaats werd aan-
nemelijk gemaakt dat het basale 13C-gehalte in de uitademing CO2 in Nederland laag is en een nor-
male verdeling heeft. Tevens werd aangetoond dat de dagelijkse fluctuatie in basale 13CO2 verrijking 
gering is. Dit bleek ook te gelden voor de fluctuatie op langere termijn.
Het volgende model werd geconstrueerd. Bij personen, die een lage 13C-verrijking hebben, wordt 
gedurende een korte periode de laag 13C-verrijkte koolhydraten vervangen door de natuurlijk ver-
rijkte koolhydraten. Deze koolhydraten zullen in de lever worden opgeslagen. Als deze weer worden 
verbrand, dan zal dit een stijging geven in de 13C-verrijking van de CO2 in de uitademinglucht.
Het model werd bij een12 gezonde proefpersonen uitgetest. [hoofdstuk 4.1]
Alle 12 proefpersonen waren gewend aan een West-Europees, laag 13C-verrijkt, dieet. Gedurende 
een dag waarop men het gebruikelijke laag 13C-verrijkte dieet volgde trad er geen fluctuatie op in 
13CO2 verrijking.
Allen kregen een dag een dieet waarvan de koolhydraten afkomstig waren van natuurlijk 13C-verrijkte 
planten. Het volgende werd waargenomen. Gedurende de dag van 13C-verrijkte koolhydraten in-
name werd een toename van de 13CO2 verrijking waargenomen, piekend na iedere met 
13C-verrijkte 
maaltijd. De voornaamste stijging werd bereikt ongeveer 2 uur na de laatste maaltijd.
Na een initiële daling in 13CO2 verrijking trad gedurende rustend vasten een plateau fase op in de 
13CO2 verrijking. Een plateau fase in 
13CO2 verrijking betekent bij gelijkblijvende CO2 productie een 
stabiele aanvoer van 13C verrijking. Dit impliceert, dat in een dergelijke situatie een constante ho-
eveelheid verrijkt leverglycogeen per tijdseenheid wordt verbrand.
De plateau fase werd gevolgd door een vrijwel lineaire daling in 13CO2 verrijking  De observatie peri-
ode bleek tekort om de 13CO2 verrijking tot de basaal waarde terug te laten keren. Dit laatste punt 
werd berekend door extrapolatie van de lineaire daling.
In het model werd ervan uitgegaan dat spierglycogeen nauwelijks verbrand wordt gedurende vasten 
in rust. En dat dus de 13C-verrijking van het spierglycogeen door de 13C-verrijkte maaltijd de interpre-
tatie van onze test als test van verbranding van leverglycogeen niet zou storen.
In een tweede studie werd dit (indirect) getoetst. [hoofdstuk 4.2] Dit werd bereikt door de hoeveelheid 
spierglycogeen fors te reduceren door middel van een flinke fiets exercitie, voordat de proefpersonen 
de 13C-verrijkte maaltijd tot zich namen. Vervolgens werd het spierglycogeen weer aangevuld door 
13C-verrijkte koolhydraten. Als spierglycogeen substantieel zou bijdragen aan de CO2 productie, dan 
zou een hogere 13C-verrijking van spierglycogeen een verstorende invloed hebben op de gemeten 
curve, die bedoeld is om de verbranding van 13C-verrijkt leverglycogeen te kunnen beoordelen. Dit 
bleek niet het geval. 
Er werd gezocht naar een andere benadering om de methode te valideren.
We redeneerden als volgt. Als het model de verbranding van 13C-verrijkt leverglycogeen weer-
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spiegelt, dan moet het mogelijk zijn om dit ook in een omgekeerd model aan te tonen. Namelijk door 
personen, die in hun dieet gebruikelijk veel 13C-verrijkte koolhydraten gebruiken, te belasten met juist 
niet verrijkte koolhydraten. Het was namelijk bekend, dat, als proefpersonen langdurig met 13C-ver-
rijkte koolhydraten (zoals maïs en rietsuiker) worden gevoed, de basale verrijking van 13CO2 op een 
substantieel hoger niveau komt te liggen.
Gebaseerd op deze gegevens hebben we in een derde studie [hoofdstuk 4.3] de volgende hypoth-
ese getoetst. Bij personen, die een dieet hebben van hoge 13C-verrijking, wordt de leverglycogeen 
voorraad na een nacht vasten aangevuld koolhydraten met een laag 13C-verrijkingsgehalte (biet-
suiker en tarweproducten). Een omgekeerde curve vergeleken met de voorgaande studies werd ver-
wacht. Deze studie werd uitgevoerd in Botswana (Zuidelijk Afrika) en toonde inderdaad de verwachte 
omgekeerde curve. Daarnaast bleek dat de vastende basale 13C-verrijkingswaarde na 24-uur vasten 
niet helemaal terugkwam op het hogere basale niveau van voor het laag 13C-verrijkte dieet. Dit sug-
gereert, dat de 13C-verrijking in vet en eiwitten bij deze personen niet dezelfde 13C-verrijking heeft als 
de koolhydraten, maar wel hoger is dan bij personen die gebruikelijk geen maïs en rietsuiker eten.
In een vierde studie [hoofdstuk 4.4] werd de reproduceerbaarheid van het ontworpen model getoetst. 
Een groep van 6 proefpersonen voerde het experiment twee maal uit met een tussenliggende peri-
ode van 6 weken. Er bleek geen duidelijk verschil tussen de beide groepen te bestaan. Wel was er 
in 2 van de 6 personen een behoorlijke variatie. Dit limiteert mogelijk het gebruik van deze methode 
voor een individuele beoordeling.
In het ontwikkelde model werd uitgegaan van het toedienen van natuurlijk 13C-verrijkte koolhydraten 
voor de periode van 1 dag. Teneinde ervoor te zorgen dat de leverglycogeen voorraad, welke ʼs 
nachts aangesproken wordt om energie via glucose te leveren, voldoende leeg zou zijn om zo veel 
mogelijk nieuw (13C-verrijkt) glucose weer op te nemen, werd de dag voor de toediening van het ver-
rijkte dieet maar 80% van de berekende energie behoefte door de proefpersonen geconsumeerd. Of 
dit voldoende 13C-verrijking van de leverglycogeen voorraad veroorzaakte was onduidelijk.
Uit de studie van Guy et al bleek dat gedurende een vijf dagenlang gebruik van een 13C-verrijkt dieet 
na 3 dagen een constante hoge verrijking van het leverglycogeen werd bereikt. 
Om te toetsen of de door ons gebruikte methode van 1 dag een 13C-verrijkt dieet voldoende was, 
werd in een vijfde studie [hoofdstuk 4.5] het 1-dags protocol vergeleken met een 3-dagen 13C-ver-
rijkt dieet protocol. Deze studie toonde aan, dat een dieet gedurende 3 dagen de leverglycogeen 
voorraad meer verrijkte. De tijd nodig voor het uitputten van de leverglycogeen voorraad was enkele 
uren langer. Dit verschil was echter dusdanig klein, dat de vraag rijst of het voor het gebruik in de 
kliniek echt noodzakelijk is om een 3-dagen dieet protocol te volgen.
Er werden ook observaties verricht bij een 12-tal patiënten met een levercirrose. De resultaten 
worden in hoofdstuk 5 weergegeven. Er werd een hogere verrijking gedurende de plateaufase gev-
onden, wat verenigbaar is met de gedachte dat de glycogeen voorraad kleiner is. Ook de relatief 
snelle daling van het 13CO2 gehalte in uitademinglucht aan het einde van de plateaufase past binnen 
dit concept.
Samengevat blijkt het dus mogelijk met een dieet, dat natuurlijk 13C-verrijkte koolhydraten bevat, 
de glycogeenvoorraad van de lever te verrijken en de verbranding van dit verrijkte lever glycogeen 
te volgen in de 13C-verrijking van uitademing CO2. Als de CO2 productie tegelijkertijd wordt gem-
eten, dan is het mogelijk met deze methode een redelijke kwantitatieve schatting te maken van 
de hoeveelheid leverglycogeen, die werd verbrand gedurende de meetperiode. Validatie van deze 
methode met bestaande methoden, zoals de NMR methode of isotopen studies, is wenselijk om tot 
een verdere validering te komen. Vervolgens zal in patiënten groepen, met name bij levercirrose 
patiënten de klinische toepasbaarheid getoetst moeten worden.
Gezien de eenvoud van handeling en bepaling is deze ademtest, mits voldoende gevalideerd, een 
veelbelovende methode voor klinische vraagstellingen en voor research doeleinden. 
Samenvatting
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Nawoord
Om met suikerriet, maïsmeel, ademlucht en een minimum aan geld de gerezen onderzoeksvraag te 
lijf te gaan was een hele uitdaging.
De genoemde ingrediënten herinnerden me sterk aan mijn verblijf in Afrika. Dit samen met het feit dat 
niet eerder dit idee was uitgewerkt brachten mij er toe de handschoen op te nemen.
 
In de loop der jaren, die het onderzoek en de bewerking in beslag nam, hebben velen mij geholpen 
en een steentje bijgedragen.
Enkelen wil ik hier persoonlijk bedanken.
Paul Wilson, internist.
Paul, je gaf ons de volledige vrijheid en het vertrouwen om het onderzoek naar eigen inzicht op te 
zetten en uit te werken. Hartelijk dank voor je kritiek en voor je support in de laatste fase. 
Jij was bereid om mij na 10 jaar tropen geneeskunde (toch nog) op te leiden tot internist. Daar ben 
ik je nog steeds dankbaar voor. Je scherpe en snelle klinische analyse is voor mij nog steeds een 
voorbeeld. 
Roel Swart, internist. 
Het was een lange weg vanaf onze eerste contacten tot de voltooiing van dit boekje. Je onderzoek 
naar het eiwitmetabolisme in patiënten met cirrhose was de basis voor mijn eigen onderzoek. Je 
stimulerende kritische geest, het steeds relativeren en het streven naar perfectie hebben mijn geest 
vaak verrijkt. De samenwerking en de uitgebreide discussies met jou en Wim zijn voor mij van grote 
waarde geweest. Jullie geduld en begrip als het weer langer duurde dan voorzien heb ik erg gewaar-
deerd. 
Wim van den Berg, biochemicus, hoofd lab interne geneeskunde II. 
De eerste vragen rondom het bestudeerde model zijn aan jou brein ontsproten. Je ideeën, je tech-
nisch inzicht, je zorgvuldigheid en je humor laten iets blijvends na. De Rhoonse avonden, waarbij ik 
bij jou thuis met jou en Roel kon brainstormen, ideeën toetsen en scherpslijpen zijn onvergetelijk. 
Trinet Rietveld, analiste op het Lab Interne II. 
Trinet, ik heb groot respect voor de manier waarop jij het analisten vak uitoefent. Je enthousiaste 
inzet en je kritische nauwkeurigheid stralen van de resultaten af. Zonder dit was het niet mogelijk 
geweest om met relatief zulke kleine marges resultaat te boeken. 
We delen een levendige interesse voor improvisatie en nieuwigheden. Het onderzoek vroeg om 
beide in ruime mate. Dit heeft veel plezier gebracht. Jouw ideeën maakten het mogelijk om thuis bij 
vrijwilligers bloed af te nemen en ʼs nachts in mijn keuken te verwerken. (Is er geen geld voor een 
opname op de balans afdeling? Dan doen we het toch thuis of op het lab).
Darcos Wattimena, analist. 
Darcos, je kritische benadering van probleemstellingen en de mogelijke antwoorden daarop hebben 
met name in de beginfase van het onderzoek veel duidelijkheid gebracht. Je nauwkeurigheid van 
werken zijn samen met die van Trinet spreekwoordelijk. Hartelijk dank voor je werk en voor je geduld 
om mij in te wijden in de wereld der isotopen. 
De staf van het lab interne II dank ik voor de gastvrijheid, het luisterend oor bij weer een presentatie 
en het helpen plakken van de posters.
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Niet onvermeld mogen blijven de vrijwilligers, zowel in Nederland als in Botswana, die als proefper-
soon mee hebben gedaan. Zonder hun bijdrage was het nooit wat geworden. Ook hen wil ik op deze 
plaats bedanken. 
De patiënten van de afdeling 4-midden ben ik dankbaar voor het zonder morren meedoen aan het 
experiment. Het was een leuke ervaring te zien dat sommige er zelfs zoveel plezier aan beleefden.
 
The Tanis  ʼfamily.
Sonja, Maryse, Maarten, Janwillem en Hein bedankt voor jullie geduld. Maar vooral bedank ik jullie, 
dat jullie kans hebben gezien om, ondanks de opleiding interne geneeskunde, de opleiding gastro-
enterologie, dit onderzoek en mijn werk als specialist, mij betrokken te houden bij allerlei andere 
aspecten die het leven biedt. Een fantastische prestatie.
De vraag naar de zin van dit alles kan alleen maar worden gesteld in het grotere verband van zin-
gevingvragen. “There is more between earth and heaven than is dreamed of in your philosophy” 
(Shakespeare). God als schepper en verlosser biedt de mogelijkheden en perspectieven om ons 
te ontplooien, zelfs in een gebroken wereld. Dit impliceert een grote verantwoordelijkheid, ook voor 
hen die wetenschap bedrijven. Het omgaan met onze gebrekkige kennis, de diversiteit in mensen en 
culturen vereist dan ook zorgvuldigheid en bescheidenheid. De bijbelse Prediker vatte het zo samen: 
“Aan het maken van boeken is geen einde, en veel studie vermoeit het lichaam. Alles gehoord heb-
bend, is de conclusie: Dien God en volg zijn geboden, want dat betaamt alle mensen.”
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Sonja, je trouw, je relativeringsvermogen en je houding van
 “een mens is wat hij is en niet wat hij heeft” 
zijn van onschatbare waarde. 
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Curriculum vitae
De auteur van dit proefschrift werd in 1956 te Kampen geboren.
In 1974 behaalde hij het VWO diploma aan de christelijke scholengemeenschap “Johannes Calvijn” 
te Rotterdam. Datzelfde jaar startte hij zijn studie geneeskunde aan de Erasmus Universiteit. Deze 
werd in 1981 afgerond. Vervolgens bereidde hij zich voor op het werk als arts in een ontwikkelings-
land in de ziekenhuizen Bergzicht en St. Anna te Goes en het Ikazia Ziekenhuis te Rotterdam.
Vanaf 1983 tot 1991 was hij werkzaam als arts in het Deborah Retief Memorial Hospital te Mochudi, 
Botswana. Van dit ziekenhuis was hij van 1984 tot 1991 tevens medisch directeur. In 1991 startte 
hij zijn opleiding tot internist in het Ikazia ziekenhuis te Rotterdam, opleider Dr. R. Ouwendijk. Vanaf 
1993 vervolgde hij deze opleiding op de afdeling inwendige geneeskunde II van het Academisch 
Ziekenhuis Rotterdam – Dijkzigt, opleider Prof. J.P.H Wilson. In 1997 volgde inschrijving als internist. 
In 1998 werd de opleiding tot maag-, darm- en leverarts afgerond, opleiders M. van Blankensteijn en 
Prof. S.W. Schalm. 
Sinds 1999 is hij werkzaam als gastroenteroloog in het Ziekenhuis Walcheren.
Hij is gehuwd en heeft 4 kinderen.
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